{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:00:46Z","timestamp":1793041246883,"version":"4.5.0"},"reference-count":321,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Institute of Cannabis Research"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-psychotropic phytocannabinoids produced by\n                    <jats:italic>Cannabis sativa<\/jats:italic>\n                    , including cannabidiol, cannabigerol, cannabichromene and their varin and acidic analogs, are emerging as promising modulators of neuroinflammation, particularly through actions on microglia, the brain\u2019s resident immune cells. These compounds engage numerous receptors, ion channels, and intracellular signaling systems in microglia associated with neuroinflammation, and therefore are promising therapeutic candidates to treat chronic microglial inflammation-mediated neurodegenerative disorders. Despite substantial public and scientific interest, comprehensive evaluation of their mechanistic diversity, disease-relevant potential, and translational gaps across neurodegenerative disorders remains limited. Commonly, gaps also exist between cannabis breeders\u2019 and cultivators\u2019 knowledge of phytocannabinoid diversity and translational scientists\u2019 understanding of therapeutic potential. In this review, we first provide an in-depth overview of the main non-psychotropic phytocannabinoids, their biosynthesis, and the genetics that control their production in cannabis. We then summarize the known mechanisms of action for each cannabinoid in microglial-expressed molecular targets and signaling pathways relevant to neuroinflammation. Lastly, we review the effects of non-psychotropic phytocannabinoids in pre-clinical models and clinical trials of four neuroinflammation-associated neurodegenerative diseases: Alzheimer\u2019s disease, Parkinson\u2019s disease, multiple sclerosis, and Huntington\u2019s disease. Current evidence supports meaningful biological activity and complex cannabinoid-specific polypharmacology, yet substantial gaps persist, especially for cannabinoids other than cannabidiol; addressing these gaps in disease-relevant models will be essential for translating these compounds into future therapeutic strategies. Further, we anticipate the summarized information will foster collaboration between cannabis breeders\/cultivators and applications scientists for therapeutic evaluation and development of emerging non-psychotropic phytocannabinoids.\n                  <\/jats:p>","DOI":"10.1186\/s42238-026-00445-5","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:06:11Z","timestamp":1778634371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cannabidiol and other non-psychotropic cannabinoids from Cannabis sativa as therapeutics for microglial-mediated neuroinflammation and neurodegeneration"],"prefix":"10.1186","volume":"8","author":[{"given":"Daniel K.","family":"Fowler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tylor M.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan I.","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"3","key":"445_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/18796397251330144","volume":"14","author":"M Abedrabbo","year":"2025","unstructured":"Abedrabbo M, Kazemian P, Connolly C, Leavitt BR. Emerging roles of microglia and neuroinflammation in Huntington\u2019s disease: from pathophysiology to clinical trials. J Huntingtons Dis. 2025;14(3):241\u201357. https:\/\/doi.org\/10.1177\/18796397251330144.","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"445_CR2","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/annrheumdis-2015-208886","volume":"76","author":"KM Alawi","year":"2017","unstructured":"Alawi KM, Russell FA, Aubdool AA, Srivastava S, Riffo-Vasquez Y, Baldissera L Jr, et al. Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation. Ann Rheum Dis. 2017;76(1):252\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"27","key":"445_CR3","doi-asserted-by":"publisher","first-page":"11256","DOI":"10.1073\/pnas.1016442108","volume":"108","author":"O Albayram","year":"2011","unstructured":"Albayram O, Alferink J, Pitsch J, Piyanova A, Neitzert K, Poppensieker K, et al. Role of CB1 cannabinoid receptors on gabaergic neurons in brain aging. Proc Natl Acad Sci. 2011;108(27):11256\u201361.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"445_CR4","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s10571-022-01249-w","volume":"43","author":"D An","year":"2023","unstructured":"An D, Qi X, Li K, Xu W, Wang Y, Chen X, et al. Blockage of TRPV4 downregulates the nuclear factor-kappa B signaling pathway to inhibit inflammatory responses and neuronal death in mice with pilocarpine-induced status epilepticus. Cell Mol Neurobiol. 2023;43(3):1283\u2013300.","journal-title":"Cell Mol Neurobiol"},{"issue":"10","key":"445_CR5","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1523\/JNEUROSCI.5369-07.2008","volume":"28","author":"DA Andersson","year":"2008","unstructured":"Andersson DA, Gentry C, Moss S, Bevan S. Transient receptor potential A1 is a sensory receptor for multiple products of oxidative stress. J Neurosci. 2008;28(10):2485\u201394.","journal-title":"J Neurosci"},{"issue":"5","key":"445_CR6","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1089\/can.2023.0101","volume":"9","author":"MA Arnanz","year":"2024","unstructured":"Arnanz MA, Ruiz de Mart\u00edn Esteban S, Mart\u00ednez Relimpio AM, Rimmerman N, Tweezer Zaks N, Grande MT, et al. Effects of chronic, low-dose cannabinoids, cannabidiol, delta-9-tetrahydrocannabinol and a combination of both, on amyloid pathology in the 5xFAD mouse model of Alzheimer\u2019s disease. Cannabis Cannabinoid Res. 2024;9(5):1312\u201325.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"3","key":"445_CR7","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1212\/WNL.42.3.631","volume":"42","author":"PV Arriagada","year":"1992","unstructured":"Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease. Neurology. 1992;42(3):631.","journal-title":"Neurology"},{"key":"445_CR8","doi-asserted-by":"publisher","first-page":"387858","DOI":"10.3389\/fnmol.2018.00295","volume":"11","author":"F Ativie","year":"2018","unstructured":"Ativie F, Komorowska JA, Beins E, Albayram \u00d6, Zimmer T, Zimmer A, et al. Cannabinoid 1 receptor signaling on hippocampal GABAergic neurons influences microglial activity. Front Mol Neurosci. 2018;11:387858.","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"445_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","volume":"160","author":"BK Atwood","year":"2010","unstructured":"Atwood BK, Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol. 2010;160(3):467\u201379.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"445_CR10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.cell.2006.02.023","volume":"124","author":"DM Bautista","year":"2006","unstructured":"Bautista DM, Jordt S-E, Nikai T, Tsuruda PR, Read AJ, Poblete J, et al. TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell. 2006;124(6):1269\u201382.","journal-title":"Cell"},{"key":"445_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-physiol-030212-183811","volume":"75","author":"DM Bautista","year":"2013","unstructured":"Bautista DM, Pellegrino M, Tsunozaki M. TRPA1: a gatekeeper for inflammation. Annu Rev Physiol. 2013;75:181\u2013200.","journal-title":"Annu Rev Physiol"},{"issue":"8","key":"445_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/glia.20477","volume":"55","author":"A B\u00e9dard","year":"2007","unstructured":"B\u00e9dard A, Tremblay P, Chernomoretz A, Valli\u00e8res L. Identification of genes preferentially expressed by microglia and upregulated during cuprizone\u2010induced inflammation. Glia. 2007;55(8):777\u201389.","journal-title":"Glia"},{"issue":"4","key":"445_CR13","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, K\u00fc\u00e7\u00fckali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"10","key":"445_CR14","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1523\/JNEUROSCI.3923-04.2005","volume":"25","author":"C Benito","year":"2005","unstructured":"Benito C, Kim W-K, Chavarr\u00eda I, Hillard CJ, Mackie K, Tol\u00f3n RM, et al. A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis. J Neurosci. 2005;25(10):2530\u20136.","journal-title":"J Neurosci"},{"key":"445_CR15","doi-asserted-by":"publisher","first-page":"628010","DOI":"10.3389\/fncel.2021.628010","volume":"15","author":"G Bergonzoni","year":"2021","unstructured":"Bergonzoni G, D\u00f6ring J, Biagioli M. D1R-and D2R-medium-sized spiny neurons diversity: insights into striatal vulnerability to Huntington\u2019s disease mutation. Front Cell Neurosci. 2021;15:628010.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"445_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2174\/138161206780574579","volume":"12","author":"A Bernardo","year":"2006","unstructured":"Bernardo A, Minghetti L. PPAR-\u03b3 agonists as regulators of microglial activation and brain inflammation. Curr Pharm des. 2006;12(1):93\u2013109.","journal-title":"Curr Pharm des"},{"issue":"1","key":"445_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41598-017-00225-5","volume":"7","author":"HS Bhatia","year":"2017","unstructured":"Bhatia HS, Roelofs N, Mu\u00f1oz E, Fiebich BL. Alleviation of microglial activation induced by p38 MAPK\/MK2\/PGE2 axis by capsaicin: potential involvement of other than TRPV1 mechanism\/s. Sci Rep. 2017;7(1):116.","journal-title":"Sci Rep"},{"issue":"4","key":"445_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13311-015-0377-3","volume":"12","author":"CI Bih","year":"2015","unstructured":"Bih CI, Chen T, Nunn AV, Bazelot M, Dallas M, Whalley BJ. Molecular targets of cannabidiol in neurological disorders. Neurotherapeutics. 2015;12(4):699\u2013730.","journal-title":"Neurotherapeutics"},{"issue":"3","key":"445_CR19","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.surg.2015.03.065","volume":"158","author":"AT Billeter","year":"2015","unstructured":"Billeter AT, Galbraith N, Walker S, Lawson C, Gardner SA, Sarojini H, et al. TRPA1 mediates the effects of hypothermia on the monocyte inflammatory response. Surgery. 2015;158(3):646\u201354.","journal-title":"Surgery"},{"issue":"4","key":"445_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/sj.bjp.0704327","volume":"134","author":"T Bisogno","year":"2001","unstructured":"Bisogno T, Hanu\u0161 L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, et al. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br J Pharmacol. 2001;134(4):845\u201352.","journal-title":"Br J Pharmacol"},{"issue":"6578","key":"445_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375(6578):296\u2013301.","journal-title":"Science"},{"issue":"10291","key":"445_CR22","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem BR, Okun MS, Klein C. Parkinson\u2019s disease. Lancet. 2021;397(10291):2284\u2013303.","journal-title":"Lancet"},{"issue":"3","key":"445_CR23","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/j.1476-5381.2010.00756.x","volume":"160","author":"D Bolognini","year":"2010","unstructured":"Bolognini D, Costa B, Maione S, Comelli F, Marini P, Di Marzo V, et al. The plant cannabinoid \u03949\u2010tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice. Br J Pharmacol. 2010;160(3):677\u201387.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"445_CR24","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/ptr.7458","volume":"36","author":"V Borgonetti","year":"2022","unstructured":"Borgonetti V, Benatti C, Governa P, Isoldi G, Pellati F, Alboni S, et al. Non\u2010psychotropic Cannabis sativa L. phytocomplex modulates microglial inflammatory response through CB2 receptors\u2010, endocannabinoids\u2010, and NF\u2010\u03baB\u2010mediated signaling. Phytother Res. 2022;36(5):2246\u201363.","journal-title":"Phytother Res"},{"issue":"14","key":"445_CR25","doi-asserted-by":"publisher","first-page":"9466","DOI":"10.1021\/acs.jmedchem.3c00061","volume":"66","author":"T Bosquez-Berger","year":"2023","unstructured":"Bosquez-Berger T, Gudorf JA, Kuntz CP, Desmond JA, Schlebach JP, VanNieuwenhze MS, et al. Structure\u2013activity relationship study of cannabidiol-based analogs as negative allosteric modulators of the \u03bc-opioid receptor. J Med Chem. 2023;66(14):9466\u201394.","journal-title":"J Med Chem"},{"issue":"3","key":"445_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ejphar.2005.05.032","volume":"517","author":"M Bouaboula","year":"2005","unstructured":"Bouaboula M, Hilairet S, Marchand J, Fajas L, Le Fur G, Casellas P. Anandamide induced PPAR\u03b3 transcriptional activation and 3T3-L1 preadipocyte differentiation. Eur J Pharmacol. 2005;517(3):174\u201381.","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"445_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","volume":"396","author":"NE Buckley","year":"2000","unstructured":"Buckley NE, McCoy KL, Mezey \u00c9, Bonner T, Zimmer A, Felder CC, et al. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor. Eur J Pharmacol. 2000;396(2\u20133):141\u20139.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"445_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1021\/acs.jnatprod.0c01034","volume":"84","author":"J Bueno","year":"2021","unstructured":"Bueno J, Greenbaum EA. (\u2212)-trans-\u03949-Tetrahydrocannabiphorol content of Cannabis sativa inflorescence from various chemotypes. J Nat Prod. 2021;84(2):531\u20136.","journal-title":"J Nat Prod"},{"key":"445_CR29","doi-asserted-by":"crossref","unstructured":"Busey GW, Manjegowda MC, Huang T, Iobst WH, Naphade SS, Kennedy JA, et al. Novel TRPM7 inhibitors with potent anti-inflammatory effects in vivo. bioRxiv. 2023:2023.05. 22.541802.","DOI":"10.1101\/2023.05.22.541802"},{"key":"445_CR30","doi-asserted-by":"crossref","unstructured":"Cabral GA, Harmon KN, Carlisle SJ. Cannabinoid-mediated inhibition of inducible nitric oxide production by rat microglial cells: evidence for CB1 receptor participation. Neuroimmune Circuits, Drugs of Abuse, and Infectious Diseases: Springer; 2002. p. 207\u201314.","DOI":"10.1007\/0-306-47611-8_24"},{"issue":"6","key":"445_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jalz.2016.01.012","volume":"12","author":"R Cacace","year":"2016","unstructured":"Cacace R, Sleegers K, Van Broeckhoven C. Molecular genetics of early-onset Alzheimer\u2019s disease revisited. Alzheimers Dement. 2016;12(6):733\u201348.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"445_CR32","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3390\/pharmaceutics12030265","volume":"12","author":"F Calapai","year":"2020","unstructured":"Calapai F, Cardia L, Sorbara EE, Navarra M, Gangemi S, Calapai G, et al. Cannabinoids, blood\u2013brain barrier, and brain disposition. Pharmaceutics. 2020;12(3):265.","journal-title":"Pharmaceutics"},{"key":"445_CR33","doi-asserted-by":"publisher","first-page":"100595","DOI":"10.1016\/j.forc.2024.100595","volume":"40","author":"C Caprari","year":"2024","unstructured":"Caprari C, Ferri E, Schmid MG, Del Mercato LL, Citti C, Cannazza G. \u03949-Tetrahydrocannabiphorol: identification and quantification in recreational products. Forensic Chem. 2024;40:100595.","journal-title":"Forensic Chem"},{"issue":"1","key":"445_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","volume":"159","author":"MG Cascio","year":"2010","unstructured":"Cascio MG, Gauson LA, Stevenson LA, Ross RA, Pertwee RG. Evidence that the plant cannabinoid cannabigerol is a highly potent \u03b12\u2010adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. Br J Pharmacol. 2010;159(1):129\u201341.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"445_CR35","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881114550355","volume":"28","author":"MHN Chagas","year":"2014","unstructured":"Chagas MHN, Zuardi AW, Tumas V, Pena-Pereira MA, Sobreira ET, Bergamaschi MM, et al. Effects of cannabidiol in the treatment of patients with Parkinson\u2019s disease: an exploratory double-blind trial. J Psychopharmacol. 2014;28(11):1088\u201398.","journal-title":"J Psychopharmacol"},{"issue":"1","key":"445_CR36","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.fct.2007.07.016","volume":"46","author":"LK Chao","year":"2008","unstructured":"Chao LK, Hua K-F, Hsu H-Y, Cheng S-S, Lin I-F, Chen C-J, et al. Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes\/macrophages through suppression of intracellular signaling. Food Chem Toxicol. 2008;46(1):220\u201331.","journal-title":"Food Chem Toxicol"},{"issue":"23","key":"445_CR37","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.3390\/cells12232672","volume":"12","author":"L Chen","year":"2023","unstructured":"Chen L, Sun Y, Li J, Liu S, Ding H, Wang G, et al. Assessing Cannabidiol as a therapeutic agent for preventing and alleviating Alzheimer\u2019s disease neurodegeneration. Cells. 2023;12(23):2672.","journal-title":"Cells"},{"issue":"1","key":"445_CR38","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-11-98","volume":"11","author":"JD Cherry","year":"2014","unstructured":"Cherry JD, Olschowka JA, O\u2019Banion MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation. 2014;11(1):98.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"445_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/intimm\/dxu097","volume":"27","author":"V Chiurchi\u00f9","year":"2015","unstructured":"Chiurchi\u00f9 V, Lanuti M, De Bardi M, Battistini L, Maccarrone M. The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells. Int Immunol. 2015;27(3):153\u201360.","journal-title":"Int Immunol"},{"issue":"6","key":"445_CR40","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.neuron.2004.08.038","volume":"43","author":"H-h Chuang","year":"2004","unstructured":"Chuang H-h, Neuhausser WM, Julius D. The super-cooling agent icilin reveals a mechanism of coincidence detection by a temperature-sensitive TRP channel. Neuron. 2004;43(6):859\u201369.","journal-title":"Neuron"},{"issue":"1","key":"445_CR41","doi-asserted-by":"publisher","first-page":"20335","DOI":"10.1038\/s41598-019-56785-1","volume":"9","author":"C Citti","year":"2019","unstructured":"Citti C, Linciano P, Russo F, Luongo L, Iannotta M, Maione S, et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than \u03949-tetrahydrocannabinol: \u03949-Tetrahydrocannabiphorol. Sci Rep. 2019;9(1):20335.","journal-title":"Sci Rep"},{"issue":"5-6","key":"445_CR42","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/07352689.2016.1267498","volume":"35","author":"RC Clarke","year":"2016","unstructured":"Clarke RC, Merlin MD. Cannabis domestication, breeding history, present-day genetic diversity, and future prospects. Crit Rev Plant Sci. 2016;35(5\u20136):293\u2013327.","journal-title":"Crit Rev Plant Sci"},{"key":"445_CR43","doi-asserted-by":"publisher","first-page":"605","DOI":"10.3389\/fneur.2018.00605","volume":"9","author":"M Colella","year":"2018","unstructured":"Colella M, Zinni M, Pansiot J, Cassanello M, Mairesse J, Ramenghi L, et al. Modulation of microglial activation by adenosine A2a receptor in animal models of perinatal brain injury. Front Neurol. 2018;9:605.","journal-title":"Front Neurol"},{"key":"445_CR44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev-immunol-051116-052358","volume":"35","author":"M Colonna","year":"2017","unstructured":"Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol. 2017;35:441\u201368.","journal-title":"Annu Rev Immunol"},{"issue":"4","key":"445_CR45","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s11481-009-9164-4","volume":"4","author":"CA Colton","year":"2009","unstructured":"Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 2009;4(4):399\u2013418.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"6460","key":"445_CR46","doi-asserted-by":"publisher","first-page":"eaav7188","DOI":"10.1126\/science.aav7188","volume":"365","author":"Consortium*\u2020 IMSG","year":"2019","unstructured":"Consortium*\u2020 IMSG, ANZgene, IIBDGC, WTCCC2. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility. Science. 2019;365(6460):eaav7188.","journal-title":"Science"},{"issue":"3","key":"445_CR47","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/0091-3057(91)90386-G","volume":"40","author":"P Consroe","year":"1991","unstructured":"Consroe P, Laguna J, Allender J, Snider S, Stern L, Sandyk R, et al. Controlled clinical trial of cannabidiol in Huntington\u2019s disease. Pharmacol Biochem Behav. 1991;40(3):701\u20138.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"445_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s42238-019-0011-z","volume":"1","author":"TA Coogan","year":"2019","unstructured":"Coogan TA. Analysis of the cannabinoid content of strains available in the New Jersey Medicinal Marijuana Program. J Cannabis Res. 2019;1(1):11.","journal-title":"J Cannabis Res"},{"issue":"6604","key":"445_CR49","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/384083a0","volume":"384","author":"BF Cravatt","year":"1996","unstructured":"Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature. 1996;384(6604):83\u20137.","journal-title":"Nature"},{"issue":"6","key":"445_CR50","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3390\/genes12060923","volume":"12","author":"S Crawford","year":"2021","unstructured":"Crawford S, Rojas BM, Crawford E, Otten M, Schoenenberger TA, Garfinkel AR, et al. Characteristics of the diploid, triploid, and tetraploid versions of a cannabigerol-dominant F1 hybrid industrial hemp cultivar, Cannabis sativa \u2018Stem Cell CBG.\u2019 Genes. 2021;12(6):923.","journal-title":"Genes"},{"issue":"1","key":"445_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol. 2020;16(1):9\u201329.","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"445_CR52","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nn.3668","volume":"17","author":"A Crotti","year":"2014","unstructured":"Crotti A, Benner C, Kerman BE, Gosselin D, Lagier-Tourenne C, Zuccato C, et al. Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors. Nat Neurosci. 2014;17(4):513\u201321.","journal-title":"Nat Neurosci"},{"issue":"8","key":"445_CR53","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1002\/glia.24374","volume":"71","author":"J Cuitavi","year":"2023","unstructured":"Cuitavi J, Andr\u00e9s\u2010Herrera P, Meseguer D, Campos\u2010Jurado Y, Lorente JD, Caruana H, et al. Focal mu\u2010opioid receptor activation promotes neuroinflammation and microglial activation in the mesocorticolimbic system: alterations induced by inflammatory pain. Glia. 2023a;71(8):1906\u201320.","journal-title":"Glia"},{"key":"445_CR54","doi-asserted-by":"publisher","first-page":"105011","DOI":"10.1016\/j.neubiorev.2022.105011","volume":"145","author":"J Cuitavi","year":"2023","unstructured":"Cuitavi J, Torres-P\u00e9rez JV, Lorente JD, Campos-Jurado Y, Andr\u00e9s-Herrera P, Polache A, et al. Crosstalk between Mu-Opioid receptors and neuroinflammation: Consequences for drug addiction and pain. Neurosci Biobehav Rev. 2023b;145:105011.","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"445_CR55","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1177\/13872877251389608","volume":"108","author":"RdM Cury","year":"2025","unstructured":"Cury RdM, Da Silva T, Cezar-dos-Santos F, Fakih YRC, Narvaez KAR, Gouvea MC, et al. A randomized clinical trial of low-dose cannabis extract in Alzheimer\u2019s disease. J Alzheimers Dis. 2025;108(4):1602\u201313.","journal-title":"J Alzheimers Dis"},{"key":"445_CR56","doi-asserted-by":"publisher","first-page":"105769","DOI":"10.1016\/j.neuint.2024.105769","volume":"177","author":"RF da Silva","year":"2024","unstructured":"da Silva RF, Newton WR, Tassinari ID\u00c1, da Cunha Xavier FH, Marx A, de Fraga LS, et al. Cannabidiol prevents LPS-induced inflammation by inhibiting the NLRP3 inflammasome and iNOS activity in BV2 microglia cells via CB2 receptors and PPAR\u03b3. Neurochem Int. 2024;177:105769.","journal-title":"Neurochem Int"},{"issue":"3","key":"445_CR57","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.bbagen.2019.01.002","volume":"1863","author":"E D'Aniello","year":"2019","unstructured":"D\u2019Aniello E, Fellous T, Iannotti FA, Gentile A, Allar\u00e0 M, Balestrieri F, et al. Identification and characterization of phytocannabinoids as novel dual PPAR\u03b1\/\u03b3 agonists by a computational and in vitro experimental approach. Biochimica Et Biophysica Acta (BBA). 2019;1863(3):586\u201397.","journal-title":"Biochimica Et Biophysica Acta (BBA)"},{"key":"445_CR58","doi-asserted-by":"publisher","first-page":"152765","DOI":"10.1016\/j.bbrc.2025.152765","volume":"787","author":"GF de Brum","year":"2025","unstructured":"de Brum GF, Lovis EP, Fontana T, Pappis L, Montagner TRS, Machado AK, et al. Transient receptor potential ankyrin 1 (TRPA1) is involved in corticosterone-induced oxidative damage in BV-2 microglial cells. Biochem Biophys Res Commun. 2025;787:152765.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"445_CR59","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.3390\/jpm11101030","volume":"11","author":"M Dehestani","year":"2021","unstructured":"Dehestani M, Liu H, Gasser T. Polygenic risk scores contribute to personalized medicine of Parkinson\u2019s disease. J Pers Med. 2021;11(10):1030.","journal-title":"J Pers Med"},{"issue":"1","key":"445_CR60","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41467-017-01739-2","volume":"8","author":"F De Logu","year":"2017","unstructured":"De Logu F, Nassini R, Materazzi S, Carvalho Gon\u00e7alves M, Nosi D, Rossi Degl\u2019Innocenti D, et al. Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice. Nat Commun. 2017;8(1):1887.","journal-title":"Nat Commun"},{"issue":"6","key":"445_CR61","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1089\/can.2020.0170","volume":"6","author":"J De Meij","year":"2021","unstructured":"De Meij J, Alfanek Z, Morel L, Decoeur F, Leyrolle Q, Picard K, et al. Microglial cannabinoid type 1 receptor regulates brain inflammation in a sex-specific manner. Cannabis Cannabinoid Res. 2021;6(6):488\u2013507.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"2","key":"445_CR62","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10681-016-1721-3","volume":"210","author":"E De Meijer","year":"2016","unstructured":"De Meijer E, Hammond K. The inheritance of chemical phenotype in Cannabis sativa L.(V): regulation of the propyl-\/pentyl cannabinoid ratio, completion of a genetic model. Euphytica. 2016;210(2):291\u2013307.","journal-title":"Euphytica"},{"issue":"7","key":"445_CR63","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","volume":"163","author":"L De Petrocellis","year":"2011","unstructured":"De Petrocellis L, Ligresti A, Moriello AS, Allar\u00e0 M, Bisogno T, Petrosino S, et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163(7):1479\u201394.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"445_CR64","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1748-1716.2011.02338.x","volume":"204","author":"L De Petrocellis","year":"2012","unstructured":"De Petrocellis L, Orlando P, Moriello AS, Aviello G, Stott C, Izzo AA, et al. Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. Acta Physiol. 2012;204(2):255\u201366.","journal-title":"Acta Physiol"},{"issue":"9","key":"445_CR65","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.yexcr.2007.01.008","volume":"313","author":"L De Petrocellis","year":"2007","unstructured":"De Petrocellis L, Starowicz K, Moriello AS, Vivese M, Orlando P, Di Marzo V. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB1 receptors and endovanilloids. Exp Cell Res. 2007;313(9):1911\u201320.","journal-title":"Exp Cell Res"},{"issue":"3","key":"445_CR66","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1124\/jpet.107.134809","volume":"325","author":"L De Petrocellis","year":"2008","unstructured":"De Petrocellis L, Vellani V, Schiano-Moriello A, Marini P, Magherini PC, Orlando P, et al. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J Pharmacol Exp Ther. 2008;325(3):1007\u201315.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"445_CR67","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","volume":"12","author":"V Di Marzo","year":"2015","unstructured":"Di Marzo V, Piscitelli F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics. 2015;12(4):692\u20138.","journal-title":"Neurotherapeutics"},{"issue":"16","key":"445_CR68","doi-asserted-by":"publisher","first-page":"10819","DOI":"10.1073\/pnas.152334899","volume":"99","author":"T Dinh","year":"2002","unstructured":"Dinh T, Carpenter D, Leslie F, Freund T, Katona I, Sensi S, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci. 2002;99(16):10819\u201324.","journal-title":"Proc Natl Acad Sci"},{"key":"445_CR69","doi-asserted-by":"publisher","first-page":"570425","DOI":"10.3389\/fimmu.2021.570425","volume":"12","author":"ER Doroshenko","year":"2021","unstructured":"Doroshenko ER, Drohomyrecky PC, Gower A, Whetstone H, Cahill LS, Ganguly M, et al. Peroxisome proliferator-activated receptor-\u03b4 deficiency in microglia results in exacerbated axonal injury and tissue loss in experimental autoimmune encephalomyelitis. Front Immunol. 2021;12:570425.","journal-title":"Front Immunol"},{"key":"445_CR70","doi-asserted-by":"publisher","first-page":"177748","DOI":"10.1016\/j.ejphar.2025.177748","volume":"1002","author":"JCC Dos Santos","year":"2025","unstructured":"Dos Santos JCC, de Aquino PEA, Rebou\u00e7as CdSM, Sallem CC, Guizardi MPP, Noleto FM, et al. Neuroprotective effects of a cannabidiol nanoemulsion in a rotenone-induced rat model of Parkinson\u2019s disease: insights into the gut-brain axis. Eur J Pharmacol. 2025;1002:177748.","journal-title":"Eur J Pharmacol"},{"key":"445_CR71","doi-asserted-by":"publisher","first-page":"154406","DOI":"10.1016\/j.tox.2026.154406","volume":"521","author":"JM Dos Santos","year":"2026","unstructured":"Dos Santos JM, Machado AK, Bick DLU, Sagrillo MR, Guimar\u00e3es EADBB, Machado AK, et al. Could cannabigerol protect against neuroinflammation? Insights from an in vitro microglial study. Toxicology. 2026;521:154406.","journal-title":"Toxicology"},{"issue":"3","key":"445_CR72","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/glia.23738","volume":"68","author":"M dos\u2010 Santos\u2010Pereira","year":"2020","unstructured":"dos\u2010 Santos\u2010Pereira M, Guimaraes FS, Del\u2010 Bel E, Raisman\u2010Vozari R, Michel PP. Cannabidiol prevents LPS\u2010induced microglial inflammation by inhibiting ROS\/NF\u2010\u03baB\u2010dependent signaling and glucose consumption. Glia. 2020;68(3):561\u201373.","journal-title":"Glia"},{"key":"445_CR73","doi-asserted-by":"publisher","first-page":"638962","DOI":"10.3389\/fpsyt.2021.638962","volume":"12","author":"L Eadie","year":"2021","unstructured":"Eadie L, Lo LA, Christiansen A, Brubacher JR, Barr AM, Panenka WJ, et al. Duration of neurocognitive impairment with medical cannabis use: a scoping review. Front Psych. 2021;12:638962.","journal-title":"Front Psych"},{"issue":"3","key":"445_CR74","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12640-016-9632-6","volume":"30","author":"S Echeverry","year":"2016","unstructured":"Echeverry S, Rodriguez MJ, Torres YP. Transient receptor potential channels in microglia: roles in physiology and disease. Neurotox Res. 2016;30(3):467\u201378.","journal-title":"Neurotox Res"},{"issue":"1","key":"445_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1742-2094-2-29","volume":"2","author":"J Ehrhart","year":"2005","unstructured":"Ehrhart J, Obregon D, Mori T, Hou H, Sun N, Bai Y, et al. Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. J Neuroinflammation. 2005;2(1):29.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"445_CR76","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuron.2005.11.027","volume":"49","author":"E Eljaschewitsch","year":"2006","unstructured":"Eljaschewitsch E, Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, et al. The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron. 2006;49(1):67\u201379.","journal-title":"Neuron"},{"issue":"7","key":"445_CR77","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","volume":"79","author":"MA ElSohly","year":"2016","unstructured":"ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. Changes in cannabis potency over the last 2 decades (1995\u20132014): analysis of current data in the United States. Biol Psychiatry. 2016;79(7):613\u20139.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"445_CR78","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/0269881115615104","volume":"30","author":"A Englund","year":"2016","unstructured":"Englund A, Atakan Z, Kralj A, Tunstall N, Murray R, Morrison P. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: a placebo-controlled, double-blind, crossover pilot trial. J Psychopharmacol. 2016;30(2):140\u201351.","journal-title":"J Psychopharmacol"},{"issue":"10","key":"445_CR79","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/jcbfm.2013.135","volume":"33","author":"MA Erickson","year":"2013","unstructured":"Erickson MA, Banks WA. Blood\u2013brain barrier dysfunction as a cause and consequence of Alzheimer\u2019s disease. J Cereb Blood Flow Metab. 2013;33(10):1500\u201313.","journal-title":"J Cereb Blood Flow Metab"},{"key":"445_CR80","doi-asserted-by":"publisher","first-page":"104892","DOI":"10.1016\/j.nbd.2020.104892","volume":"141","author":"I Espadas","year":"2020","unstructured":"Espadas I, Keifman E, Palomo-Garo C, Burgaz S, Garc\u00eda C, Fern\u00e1ndez-Ruiz J, et al. Beneficial effects of the phytocannabinoid \u03949-THCV in L-DOPA-induced dyskinesia in Parkinson\u2019s disease. Neurobiol Dis. 2020;141:104892.","journal-title":"Neurobiol Dis"},{"issue":"8","key":"445_CR81","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/sj.bjp.0707337","volume":"151","author":"G Esposito","year":"2007","unstructured":"Esposito G, Scuderi C, Savani C, Steardo L Jr, De Filippis D, Cottone P, et al. Cannabidiol in vivo blunts \u03b2\u2010amyloid induced neuroinflammation by suppressing IL\u20101\u03b2 and iNOS expression. Br J Pharmacol. 2007;151(8):1272\u20139.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"445_CR82","doi-asserted-by":"publisher","first-page":"e28668","DOI":"10.1371\/journal.pone.0028668","volume":"6","author":"G Esposito","year":"2011","unstructured":"Esposito G, Scuderi C, Valenza M, Togna GI, Latina V, De Filippis D, et al. Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement. PLoS ONE. 2011;6(12):e28668.","journal-title":"PLoS ONE"},{"key":"445_CR83","doi-asserted-by":"publisher","first-page":"120582","DOI":"10.1016\/j.lfs.2022.120582","volume":"300","author":"L Etemad","year":"2022","unstructured":"Etemad L, Karimi G, Alavi MS, Roohbakhsh A. Pharmacological effects of cannabidiol by transient receptor potential channels. Life Sci. 2022;300:120582.","journal-title":"Life Sci"},{"issue":"5","key":"445_CR84","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1165\/rcmb.2007-0130OC","volume":"37","author":"F Facchinetti","year":"2007","unstructured":"Facchinetti F, Amadei F, Geppetti P, Tarantini F, Di Serio C, Dragotto A, et al. \u03b1, \u03b2-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol. 2007;37(5):617\u201323.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"445_CR85","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0014-5793(98)00450-5","volume":"427","author":"M Fellermeier","year":"1998","unstructured":"Fellermeier M, Zenk MH. Prenylation of olivetolate by a hemp transferase yields cannabigerolic acid, the precursor of tetrahydrocannabinol. FEBS Lett. 1998;427(2):283\u20135.","journal-title":"FEBS Lett"},{"key":"445_CR86","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fnmol.2017.00200","volume":"10","author":"AJ Fenwick","year":"2017","unstructured":"Fenwick AJ, Fowler DK, Wu S-W, Shaffer FJ, Lindberg JE, Kinch DC, et al. Direct anandamide activation of TRPV1 produces divergent calcium and current responses. Front Mol Neurosci. 2017;10:200.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"445_CR87","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/biom13020376","volume":"13","author":"S Fleisher-Berkovich","year":"2023","unstructured":"Fleisher-Berkovich S, Ventura Y, Amoyal M, Dahan A, Feinshtein V, Alfahel L, et al. Therapeutic potential of phytocannabinoid cannabigerol for multiple sclerosis: modulation of microglial activation in vitro and in vivo. Biomolecules. 2023;13(2):376.","journal-title":"Biomolecules"},{"issue":"1","key":"445_CR88","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.phrs.2012.11.002","volume":"68","author":"JM Franklin","year":"2013","unstructured":"Franklin JM, Vasiljevik T, Prisinzano TE, Carrasco GA. Cannabinoid agonists increase the interaction between \u03b2-Arrestin 2 and ERK1\/2 and upregulate \u03b2-Arrestin 2 and 5-HT2A receptors. Pharmacol Res. 2013;68(1):46\u201358.","journal-title":"Pharmacol Res"},{"key":"445_CR89","doi-asserted-by":"crossref","unstructured":"Freichel M, Tsvilovskyy V, Camacho-Londo\u00f1o JE. TRPC4-and TRPC4-containing channels. Mammalian Transient Receptor Potential (TRP) Cation Channels: Volume I. 2014:85\u2013128.","DOI":"10.1007\/978-3-642-54215-2_5"},{"issue":"9","key":"445_CR90","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.3390\/plants10091857","volume":"10","author":"F Fulvio","year":"2021","unstructured":"Fulvio F, Paris R, Montanari M, Citti C, Cilento V, Bassolino L, et al. Analysis of sequence variability and transcriptional profile of cannabinoid synthase genes in Cannabis sativa L. chemotypes with a focus on cannabichromenic acid synthase. Plants. 2021;10(9):1857.","journal-title":"Plants"},{"issue":"6","key":"445_CR91","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.bja.2019.08.026","volume":"123","author":"J Gao","year":"2019","unstructured":"Gao J, Sun Z, Xiao Z, Du Q, Niu X, Wang G, et al. Dexmedetomidine modulates neuroinflammation and improves outcome via alpha2-adrenergic receptor signaling after rat spinal cord injury. Br J Anaesth. 2019;123(6):827\u201338.","journal-title":"Br J Anaesth"},{"key":"445_CR92","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.freeradbiomed.2025.04.049","volume":"235","author":"X Gao","year":"2025","unstructured":"Gao X, Fu S, Liu Y, Yan A, Sun Y, Li X, et al. TRPM8 activation inhibits neuroinflammation and ameliorates neurodegeneration by modulating Nrf2\/HO-1 and NF-\u03baB pathways in vivo and in vitro. Free Radic Biol Med. 2025;235:248\u201360.","journal-title":"Free Radic Biol Med"},{"key":"445_CR93","doi-asserted-by":"publisher","first-page":"118288","DOI":"10.1016\/j.biopha.2025.118288","volume":"189","author":"L Garc\u00eda-Toscano","year":"2025","unstructured":"Garc\u00eda-Toscano L, Rodr\u00edguez-Cueto C, Furiano A, Hind W, de Lago E, Fern\u00e1ndez-Ruiz J. Preclinical evaluation of cannabidiolic acid as a neuroprotective agent in TDP-43 transgenic mice, an experimental model of amyotrophic lateral sclerosis. Biomed Pharmacother. 2025;189:118288.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"445_CR94","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/genes12020228","volume":"12","author":"AR Garfinkel","year":"2021","unstructured":"Garfinkel AR, Otten M, Crawford S. SNP in potentially defunct tetrahydrocannabinolic acid synthase is a marker for cannabigerolic acid dominance in Cannabis sativa L. Genes. 2021;12(2):228.","journal-title":"Genes"},{"issue":"1","key":"445_CR95","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","volume":"118","author":"LR Gauthier","year":"2004","unstructured":"Gauthier LR, Charrin BC, Borrell-Pag\u00e8s M, Dompierre JP, Rangone H, Cordeli\u00e8res FP, et al. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell. 2004;118(1):127\u201338.","journal-title":"Cell"},{"key":"445_CR96","doi-asserted-by":"publisher","first-page":"100056","DOI":"10.1016\/j.prdoa.2020.100056","volume":"3","author":"EM Gatto","year":"2020","unstructured":"Gatto EM, Rojas NG, Persi G, Etcheverry JL, Cesarini ME, Perandones C. Huntington disease: Advances in the understanding of its mechanisms. Clin Parkinsonism Relat Disord. 2020;3:100056.","journal-title":"Clin Parkinsonism Relat Disord"},{"issue":"1","key":"445_CR97","first-page":"2749","volume":"61","author":"S Giacoppo","year":"2017","unstructured":"Giacoppo S, Gugliandolo A, Trubiani O, Pollastro F, Grassi G, Bramanti P, et al. Cannabinoid CB2 receptors are involved in the protection of RAW264. 7 macrophages against the oxidative stress: an in vitro study. Eur J Histochem EJH. 2017;61(1):2749.","journal-title":"Eur J Histochem EJH."},{"issue":"1","key":"445_CR98","doi-asserted-by":"publisher","first-page":"20822","DOI":"10.1038\/s41598-025-03854-3","volume":"15","author":"G Giordano","year":"2025","unstructured":"Giordano G, Brook CP, Ortiz Torres M, MacDonald G, Skrzynski CJ, Lisano JK, et al. Accuracy of labeled THC potency across flower and concentrate cannabis products. Sci Rep. 2025;15(1):20822.","journal-title":"Sci Rep"},{"issue":"16","key":"445_CR99","doi-asserted-by":"publisher","first-page":"8920","DOI":"10.3390\/ijms22168920","volume":"22","author":"C Giuliano","year":"2021","unstructured":"Giuliano C, Francavilla M, Ongari G, Petese A, Ghezzi C, Rossini N, et al. Neuroprotective and symptomatic effects of cannabidiol in an animal model of Parkinson\u2019s disease. Int J Mol Sci. 2021;22(16):8920.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"445_CR100","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u201334.","journal-title":"Cell"},{"issue":"18","key":"445_CR101","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.3390\/molecules28186487","volume":"28","author":"EG Gojani","year":"2023","unstructured":"Gojani EG, Wang B, Li D-P, Kovalchuk O, Kovalchuk I. Anti-inflammatory effects of minor cannabinoids CBC, THCV, and CBN in human macrophages. Molecules. 2023;28(18):6487.","journal-title":"Molecules"},{"issue":"4","key":"445_CR102","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1007\/s11481-012-9399-3","volume":"7","author":"AG Granja","year":"2012","unstructured":"Granja AG, Carrillo-Salinas F, Pagani A, G\u00f3mez-Ca\u00f1as M, Negri R, Navarrete C, et al. A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis. J Neuroimmune Pharmacol. 2012;7(4):1002\u201316.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"4","key":"445_CR103","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1111\/nph.17243","volume":"230","author":"CJ Grassa","year":"2021","unstructured":"Grassa CJ, Weiblen GD, Wenger JP, Dabney C, Poplawski SG, Motley S, et al. A new Cannabis genome assembly associates elevated cannabidiol (CBD) with hemp introgressed into marijuana. New Phytol. 2021;230(4):1665\u201379.","journal-title":"New Phytol"},{"issue":"2","key":"445_CR104","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/ph18020160","volume":"18","author":"L Grifoni","year":"2025","unstructured":"Grifoni L, Landucci E, Pieraccini G, Mazzantini C, Bergonzi MC, Pellegrini-Giampietro DE, et al. Development and blood\u2013brain barrier penetration of nanovesicles loaded with cannabidiol. Pharmaceuticals. 2025;18(2):160.","journal-title":"Pharmaceuticals"},{"issue":"4","key":"445_CR105","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","volume":"42","author":"F Grotenhermen","year":"2003","unstructured":"Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327\u201360.","journal-title":"Clin Pharmacokinet"},{"key":"445_CR106","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3389\/fimmu.2020.00374","volume":"11","author":"BL Guerrero","year":"2020","unstructured":"Guerrero BL, Sicotte NL. Microglia in multiple sclerosis: friend or foe? Front Immunol. 2020;11:374.","journal-title":"Front Immunol"},{"issue":"1","key":"445_CR107","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41598-017-00342-1","volume":"7","author":"F Guida","year":"2017","unstructured":"Guida F, Luongo L, Boccella S, Giordano M, Romano R, Bellini G, et al. Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: involvement of the CB2 receptor. Sci Rep. 2017;7(1):375.","journal-title":"Sci Rep"},{"issue":"7","key":"445_CR108","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3390\/ijms19071992","volume":"19","author":"A Gugliandolo","year":"2018","unstructured":"Gugliandolo A, Pollastro F, Grassi G, Bramanti P, Mazzon E. In vitro model of neuroinflammation: efficacy of cannabigerol, a non-psychoactive cannabinoid. Int J Mol Sci. 2018;19(7):1992.","journal-title":"Int J Mol Sci"},{"issue":"21","key":"445_CR109","doi-asserted-by":"publisher","first-page":"15291","DOI":"10.1074\/jbc.M113.458901","volume":"288","author":"S Gyoneva","year":"2013","unstructured":"Gyoneva S, Traynelis SF. Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors. J Biol Chem. 2013;288(21):15291\u2013302.","journal-title":"J Biol Chem"},{"issue":"5054","key":"445_CR110","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"9","key":"445_CR111","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1038\/s41401-021-00853-8","volume":"43","author":"Q-w Han","year":"2022","unstructured":"Han Q-w, Shao Q-h, Wang X-t, Ma K-l, Chen N-h, Yuan Y-h. CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK\/AKT-Nurr1 signal pathways. Acta Pharmacol Sin. 2022;43(9):2253\u201366.","journal-title":"Acta Pharmacol Sin"},{"key":"445_CR112","doi-asserted-by":"publisher","first-page":"1431758","DOI":"10.3389\/fphar.2024.1431758","volume":"15","author":"Y Han","year":"2024","unstructured":"Han Y, Wang S, Xiang Y, Chang L, Wang X, Ren S, et al. Cannabidiol inhibits transient receptor potential canonical 4 and modulates excitability of pyramidal neurons in mPFC. Front Pharmacol. 2024;15:1431758.","journal-title":"Front Pharmacol"},{"issue":"8","key":"445_CR113","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.3390\/ph16081079","volume":"16","author":"JS Hansen","year":"2023","unstructured":"Hansen JS, Gustavsen S, Roshanisefat H, Kant M, Biering-S\u00f8rensen F, Andersen C, et al. Cannabis-based medicine for neuropathic pain and spasticity\u2014a multicenter, randomized, double-blinded, placebo-controlled trial. Pharmaceuticals. 2023;16(8):1079.","journal-title":"Pharmaceuticals"},{"issue":"9","key":"445_CR114","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/bph.12615","volume":"171","author":"S Hassan","year":"2014","unstructured":"Hassan S, Eldeeb K, Millns PJ, Bennett AJ, Alexander SP, Kendall DA. Cannabidiol enhances microglial phagocytosis via transient receptor potential (TRP) channel activation. Br J Pharmacol. 2014;171(9):2426\u201339.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"445_CR115","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405.","journal-title":"Lancet Neurol"},{"issue":"4","key":"445_CR116","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(14)70305-9","volume":"14","author":"B Hemmer","year":"2015","unstructured":"Hemmer B, Kerschensteiner M, Korn T. Role of the innate and adaptive immune responses in the course of multiple sclerosis. The Lancet Neurology. 2015;14(4):406\u201319.","journal-title":"The Lancet Neurology"},{"key":"445_CR117","doi-asserted-by":"publisher","first-page":"109428","DOI":"10.1016\/j.abb.2022.109428","volume":"731","author":"M Hirao-Suzuki","year":"2022","unstructured":"Hirao-Suzuki M, Takayuki K, Takiguchi M, Peters JM, Takeda S. Cannabidiolic acid activates the expression of the PPAR\u03b2\/\u03b4 target genes in MDA-MB-231 cells. Arch Biochem Biophys. 2022;731:109428.","journal-title":"Arch Biochem Biophys"},{"key":"445_CR118","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-981-13-9913-8_13","volume":"1175","author":"MS Ho","year":"2019","unstructured":"Ho MS. Microglia in Parkinson\u2019s disease. Neuroglia in neurodegenerative diseases. Adv Exp Med Biol. 2019;1175:335\u201353.","journal-title":"Adv Exp Med Biol"},{"issue":"23","key":"445_CR119","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.3390\/plants12233966","volume":"12","author":"M Hong","year":"2023","unstructured":"Hong M, Kim J-H, Han J-H, Ryu B-R, Lim Y-S, Lim J-D, et al. In vitro and in vivo anti-inflammatory potential of cannabichromene isolated from hemp. Plants Basel. 2023;12(23):3966.","journal-title":"Plants Basel"},{"key":"445_CR120","doi-asserted-by":"publisher","first-page":"1280257","DOI":"10.3389\/fcell.2023.1280257","volume":"11","author":"W Huang","year":"2023","unstructured":"Huang W, Huang J, Huang N, Luo Y. The role of TREM2 in Alzheimer\u2019s disease: from the perspective of Tau. Front Cell Dev Biol. 2023;11:1280257.","journal-title":"Front Cell Dev Biol"},{"issue":"11","key":"445_CR121","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1038\/jcbfm.2015.128","volume":"35","author":"JH Huck","year":"2015","unstructured":"Huck JH, Freyer D, B\u00f6ttcher C, Mladinov M, Muselmann-Genschow C, Thielke M, et al. De novo expression of dopamine D2 receptors on microglia after stroke. J Cereb Blood Flow Metab. 2015;35(11):1804\u201311.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"8","key":"445_CR122","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis MA. Human cannabinoid pharmacokinetics. Chem Biodivers. 2007;4(8):1770.","journal-title":"Chem Biodivers"},{"issue":"1","key":"445_CR123","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12974-021-02321-w","volume":"18","author":"S Huo","year":"2021","unstructured":"Huo S, Ren J, Ma Y, Ozathaley A, Yuan W, Ni H, et al. Upregulation of TRPC5 in hippocampal excitatory synapses improves memory impairment associated with neuroinflammation in microglia knockout IL-10 mice. J Neuroinflammation. 2021;18(1):275.","journal-title":"J Neuroinflammation"},{"issue":"11","key":"445_CR124","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1021\/cn5000524","volume":"5","author":"FA Iannotti","year":"2014","unstructured":"Iannotti FA, Hill CL, Leo A, Alhusaini A, Soubrane C, Mazzarella E, et al. Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro: potential for the treatment of neuronal hyperexcitability. ACS Chem Neurosci. 2014;5(11):1131\u201341.","journal-title":"ACS Chem Neurosci"},{"issue":"7","key":"445_CR125","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Kiyak YB, Akbayir R, Seyhali R, Arpaci T. Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells. 2023;12(7):1012.","journal-title":"Cells"},{"issue":"4","key":"445_CR126","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1476-5381.2012.01879.x","volume":"166","author":"AA Izzo","year":"2012","unstructured":"Izzo AA, Capasso R, Aviello G, Borrelli F, Romano B, Piscitelli F, et al. Inhibitory effect of cannabichromene, a major non\u2010psychotropic cannabinoid extracted from Cannabis sativa, on inflammation\u2010induced hypermotility in mice. Br J Pharmacol. 2012;166(4):1444\u201360.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"445_CR127","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, et al. NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"15","key":"445_CR128","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.3390\/ijms22158338","volume":"22","author":"A Jan","year":"2021","unstructured":"Jan A, Goncalves NP, Vaegter CB, Jensen PH, Ferreira N. The prion-like spreading of alpha-synuclein in Parkinson\u2019s disease: update on models and hypotheses. Int J Mol Sci. 2021;22(15):8338.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"445_CR129","doi-asserted-by":"publisher","first-page":"e12774","DOI":"10.1111\/acel.12774","volume":"17","author":"J Ji","year":"2018","unstructured":"Ji J, Xue TF, Guo XD, Yang J, Guo RB, Wang J, et al. Antagonizing peroxisome proliferator-activated receptor \u03b3 facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB 1\u2013AMPK signaling pathway. Aging Cell. 2018;17(4):e12774.","journal-title":"Aging Cell"},{"key":"445_CR130","doi-asserted-by":"publisher","first-page":"993168","DOI":"10.3389\/fimmu.2022.993168","volume":"13","author":"F Jiang","year":"2022","unstructured":"Jiang F, Xia M, Zhang Y, Chang J, Cao J, Zhang Z, et al. Cannabinoid receptor-2 attenuates neuroinflammation by promoting autophagy-mediated degradation of the NLRP3 inflammasome post spinal cord injury. Front Immunol. 2022;13:993168.","journal-title":"Front Immunol"},{"issue":"1","key":"445_CR131","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1038\/s41598-018-22755-2","volume":"8","author":"N Jikomes","year":"2018","unstructured":"Jikomes N, Zoorob M. The cannabinoid content of legal cannabis in Washington state varies systematically across testing facilities and popular consumer products. Sci Rep. 2018;8(1):4519.","journal-title":"Sci Rep"},{"issue":"5","key":"445_CR132","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/s00210-006-0033-x","volume":"372","author":"M Kathmann","year":"2006","unstructured":"Kathmann M, Flau K, Redmer A, Tr\u00e4nkle C, Schlicker E. Cannabidiol is an allosteric modulator at mu-and delta-opioid receptors. Naunyn Schmiedebergs Arch Pharmacol. 2006;372(5):354\u201361.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"445_CR133","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169(7):1276-90.e17.","journal-title":"Cell"},{"issue":"6","key":"445_CR134","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/mi.2016.16","volume":"9","author":"M Khalil","year":"2016","unstructured":"Khalil M, Babes A, Lakra R, F\u00f6rsch S, Reeh P, Wirtz S, et al. Transient receptor potential melastatin 8 ion channel in macrophages modulates colitis through a balance-shift in TNF-alpha and interleukin-10 production. Mucosal Immunol. 2016;9(6):1500\u201313.","journal-title":"Mucosal Immunol"},{"issue":"7","key":"445_CR135","doi-asserted-by":"publisher","first-page":"6827","DOI":"10.3390\/ijms24076827","volume":"24","author":"J Kim","year":"2023","unstructured":"Kim J, Choi P, Park Y-T, Kim T, Ham J, Kim J-C. The cannabinoids, CBDA and THCA, rescue memory deficits and reduce amyloid-beta and Tau pathology in an Alzheimer\u2019s disease-like mouse model. Int J Mol Sci. 2023a;24(7):6827.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"445_CR136","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.3390\/molecules28186439","volume":"28","author":"J-H Kim","year":"2023","unstructured":"Kim J-H, Hong M, Han J-H, Ryu BR, Lim YS, Lim JD, et al. In vitro and in vivo anti-inflammatory effects of cannabidiol isolated from novel hemp (Cannabis sativa L.) cultivar Pink Pepper. Molecules. 2023b;28(18):6439.","journal-title":"Molecules"},{"key":"445_CR137","doi-asserted-by":"publisher","first-page":"e2509034","DOI":"10.4014\/jmb.2509.09034","volume":"35","author":"J-H Kim","year":"2025","unstructured":"Kim J-H, Hong M, Han J-H, Ryu BR, Lim JD, Kim K-C, et al. Cannabigerol exerts in vivo and in vitro anti-inflammatory effects via inhibition of the MAPK and NF-\u03baB pathways. J Microbiol Biotechnol. 2025;35:e2509034.","journal-title":"J Microbiol Biotechnol"},{"issue":"5","key":"445_CR138","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/glia.22306","volume":"60","author":"M Konno","year":"2012","unstructured":"Konno M, Shirakawa H, Iida S, Sakimoto S, Matsutani I, Miyake T, et al. Stimulation of transient receptor potential vanilloid 4 channel suppresses abnormal activation of microglia induced by lipopolysaccharide. Glia. 2012;60(5):761\u201370.","journal-title":"Glia"},{"issue":"7","key":"445_CR139","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1111\/j.1476-5381.2011.01379.x","volume":"163","author":"E Kozela","year":"2011","unstructured":"Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, et al. Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL\/6 mice. Br J Pharmacol. 2011;163(7):1507\u201319.","journal-title":"Br J Pharmacol"},{"issue":"36","key":"445_CR140","doi-asserted-by":"publisher","first-page":"e2103084118","DOI":"10.1073\/pnas.2103084118","volume":"118","author":"S Krishna","year":"2021","unstructured":"Krishna S, Cheng B, Sharma DR, Yadav S, Stempinski ES, Mamtani S, et al. PPAR-\u03b3 activation enhances myelination and neurological recovery in premature rabbits with intraventricular hemorrhage. Proc Natl Acad Sci. 2021;118(36):e2103084118.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"445_CR141","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates A\u03b2, tau, immunity and lipid processing. Nat Genet. 2019;51(3):414\u201330.","journal-title":"Nat Genet"},{"issue":"11","key":"445_CR142","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1093\/brain\/awh641","volume":"128","author":"A Kutzelnigg","year":"2005","unstructured":"Kutzelnigg A, Lucchinetti CF, Stadelmann C, Br\u00fcck W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005;128(11):2705\u201312.","journal-title":"Brain"},{"issue":"20","key":"445_CR143","doi-asserted-by":"publisher","first-page":"12144","DOI":"10.3390\/ijms232012144","volume":"23","author":"D Lana","year":"2022","unstructured":"Lana D, Landucci E, Mazzantini C, Magni G, Pellegrini-Giampietro DE, Giovannini MG. The protective effect of CBD in a model of in vitro ischemia may be mediated by agonism on TRPV2 channel and microglia activation. Int J Mol Sci. 2022;23(20):12144.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"445_CR144","doi-asserted-by":"publisher","first-page":"e0126839","DOI":"10.1371\/journal.pone.0126839","volume":"10","author":"M Lanuti","year":"2015","unstructured":"Lanuti M, Talamonti E, Maccarrone M, Chiurchiu V. Activation of GPR55 receptors exacerbates oxLDL-induced lipid accumulation and inflammatory responses, while reducing cholesterol efflux from human macrophages. PLoS ONE. 2015;10(5):e0126839.","journal-title":"PLoS ONE"},{"issue":"20","key":"445_CR145","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie RB, Bagher AM, Kelly M, Denovan\u2010Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015;172(20):4790\u2013805.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"445_CR146","doi-asserted-by":"publisher","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann H. Multiple sclerosis pathology. Cold Spring Harb Perspect Med. 2018;8(3):a028936.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"445_CR147","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1073\/pnas.0711278105","volume":"105","author":"JE Lauckner","year":"2008","unstructured":"Lauckner JE, Jensen JB, Chen H-Y, Lu H-C, Hille B, Mackie K. GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current. Proc Natl Acad Sci U S A. 2008;105(7):2699\u2013704.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"445_CR148","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbrc.2017.05.165","volume":"490","author":"AS Laun","year":"2017","unstructured":"Laun AS, Song Z-H. GPR3 and GPR6, novel molecular targets for cannabidiol. Biochem Biophys Res Commun. 2017;490(1):17\u201321.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"445_CR149","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41401-018-0031-9","volume":"40","author":"AS Laun","year":"2019","unstructured":"Laun AS, Shrader SH, Brown KJ, Song Z-H. GPR3, GPR6, and GPR12 as novel molecular targets: their biological functions and interaction with cannabidiol. Acta Pharmacol Sin. 2019;40(3):300\u20138.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"445_CR150","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1101\/gr.242594.118","volume":"29","author":"KU Laverty","year":"2019","unstructured":"Laverty KU, Stout JM, Sullivan MJ, Shah H, Gill N, Holbrook L, et al. A physical and genetic map of Cannabis sativa identifies extensive rearrangements at the THC\/CBD acid synthase loci. Genome Res. 2019;29(1):146\u201356.","journal-title":"Genome Res"},{"issue":"4","key":"445_CR151","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/can.2019.0068","volume":"5","author":"MA Leehey","year":"2020","unstructured":"Leehey MA, Liu Y, Hart F, Epstein C, Cook M, Sillau S, et al. Safety and tolerability of cannabidiol in Parkinson disease: an open label, dose-escalation study. Cannabis Cannabinoid Res. 2020;5(4):326\u201336.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"14","key":"445_CR152","doi-asserted-by":"publisher","first-page":"8514","DOI":"10.1073\/pnas.1432609100","volume":"100","author":"S Lehnardt","year":"2003","unstructured":"Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003;100(14):8514\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"445_CR153","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.1038\/s41598-018-22558-5","volume":"8","author":"M L\u00e9v\u00eaque","year":"2018","unstructured":"L\u00e9v\u00eaque M, Penna A, Le Trionnaire S, Belleguic C, Desrues B, Brinchault G, et al. Phagocytosis depends on TRPV2-mediated calcium influx and requires TRPV2 in lipids rafts: alteration in macrophages from patients with cystic fibrosis. Sci Rep. 2018;8(1):4310.","journal-title":"Sci Rep"},{"key":"445_CR154","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbi.2022.06.003","volume":"104","author":"M Li","year":"2022","unstructured":"Li M, Xu B, Li X, Li Y, Qiu S, Chen K, et al. Mitofusin 2 confers the suppression of microglial activation by cannabidiol: insights from in vitro and in vivo models. Brain Behav Immun. 2022;104:155\u201370.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"445_CR155","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","volume":"18","author":"Q Li","year":"2018","unstructured":"Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18(4):225\u201342.","journal-title":"Nat Rev Immunol"},{"key":"445_CR156","doi-asserted-by":"publisher","first-page":"620525","DOI":"10.3389\/fnins.2021.620525","volume":"15","author":"X Li","year":"2021","unstructured":"Li X, Guo Q, Ye Z, Wang E, Zou W, Sun Z, et al. PPAR \u03b3 prevents neuropathic pain by down-regulating CX3CR1 and attenuating M1 activation of microglia in the spinal cord of rats using a sciatic chronic constriction injury model. Front Neurosci. 2021a;15:620525.","journal-title":"Front Neurosci"},{"key":"445_CR157","doi-asserted-by":"publisher","first-page":"719807","DOI":"10.3389\/fimmu.2021.719807","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Xia Y, Yin S, Wan F, Hu J, Kou L, et al. Targeting microglial \u03b1-synuclein\/TLRs\/NF-kappaB\/NLRP3 inflammasome axis in Parkinson\u2019s disease. Front Immunol. 2021b;12:719807.","journal-title":"Front Immunol"},{"key":"445_CR158","doi-asserted-by":"publisher","first-page":"109655","DOI":"10.1016\/j.intimp.2022.109655","volume":"115","author":"Y Lin","year":"2023","unstructured":"Lin Y, Cui X, Cao Q, Bi R, Liu Y, Jing D, et al. TRPC absence induces pro-inflammatory macrophages and gut microbe disorder, sensitizing mice to colitis. Int Immunopharmacol. 2023;115:109655.","journal-title":"Int Immunopharmacol"},{"key":"445_CR159","doi-asserted-by":"publisher","first-page":"1392328","DOI":"10.3389\/fphar.2024.1392328","volume":"15","author":"Y Lin","year":"2024","unstructured":"Lin Y, Gao R, Jing D, Liu Y, Da H, Birnbaumer L, et al. TRPC absence induces pro-inflammatory macrophage polarization to promote obesity and exacerbate colorectal cancer. Front Pharmacol. 2024;15:1392328.","journal-title":"Front Pharmacol"},{"issue":"3","key":"445_CR160","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ni.1842","volume":"11","author":"TM Link","year":"2010","unstructured":"Link TM, Park U, Vonakis BM, Raben DM, Soloski MJ, Caterina MJ. TRPV2 has a pivotal role in macrophage particle binding and phagocytosis. Nat Immunol. 2010;11(3):232\u20139.","journal-title":"Nat Immunol"},{"issue":"2","key":"445_CR161","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1136\/svn-2016-000012","volume":"1","author":"H Liu","year":"2016","unstructured":"Liu H, Leak RK, Hu X. Neurotransmitter receptors on microglia. Stroke Vasc Neurol. 2016;1(2):52\u20138.","journal-title":"Stroke Vasc Neurol."},{"issue":"1","key":"445_CR162","doi-asserted-by":"publisher","first-page":"7855","DOI":"10.1038\/s41598-023-34789-2","volume":"13","author":"M Liu","year":"2023","unstructured":"Liu M, Liu H, Feng F, Krook-Magnuson E, Dudley SC. TRPM7 kinase mediates hypomagnesemia-induced seizure-related death. Sci Rep. 2023;13(1):7855.","journal-title":"Sci Rep"},{"key":"445_CR163","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3389\/fncel.2018.00392","volume":"12","author":"M Liu","year":"2018","unstructured":"Liu M, Liu X, Wang L, Wang Y, Dong F, Wu J, et al. TRPV4 inhibition improved myelination and reduced glia reactivity and inflammation in a cuprizone-induced mouse model of demyelination. Front Cell Neurosci. 2018;12:392.","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"445_CR164","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/antiox11091682","volume":"11","author":"L Longhitano","year":"2022","unstructured":"Longhitano L, Distefano A, Murabito P, Astuto M, Nicolosi A, Buscema G, et al. Propofol and \u03b12-agonists attenuate microglia activation and restore mitochondrial function in an in vitro model of microglia hypoxia\/reoxygenation. Antioxidants Basel. 2022;11(9):1682.","journal-title":"Antioxidants Basel"},{"issue":"1","key":"445_CR165","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41588-021-00976-y","volume":"54","author":"KdP Lopes","year":"2022","unstructured":"Lopes KdP, Snijders GJ, Humphrey J, Allan A, Sneeboer MA, Navarro E, et al. Genetic analysis of the human microglial transcriptome across brain regions, aging and disease pathologies. Nat Genet. 2022;54(1):4\u201317.","journal-title":"Nat Genet"},{"issue":"6","key":"445_CR166","first-page":"607","volume":"6","author":"H-C Lu","year":"2021","unstructured":"Lu H-C, Mackie K. Review of the endocannabinoid system. Biol Psychiatry Cogn Neurosci Neuroimaging. 2021;6(6):607\u201315.","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"issue":"7746","key":"445_CR167","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41586-019-0978-9","volume":"567","author":"X Luo","year":"2019","unstructured":"Luo X, Reiter MA, d\u2019Espaux L, Wong J, Denby CM, Lechner A, et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature. 2019;567(7746):123\u20136.","journal-title":"Nature"},{"issue":"8073","key":"445_CR168","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41586-025-09065-0","volume":"643","author":"RC Lynch","year":"2025","unstructured":"Lynch RC, Padgitt-Cobb LK, Garfinkel AR, Knaus BJ, Hartwick NT, Allsing N, et al. Domesticated cannabinoid synthases amid a wild mosaic cannabis pangenome. Nature. 2025;643(8073):1001\u201310.","journal-title":"Nature"},{"issue":"1","key":"445_CR169","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.pharmtox.46.120604.141254","volume":"46","author":"K Mackie","year":"2006","unstructured":"Mackie K. Cannabinoid receptors as therapeutic targets. Annu Rev Pharmacol Toxicol. 2006;46(1):101\u201322.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"445_CR170","doi-asserted-by":"publisher","first-page":"726","DOI":"10.3389\/fpsyt.2018.00726","volume":"9","author":"T Maduna","year":"2019","unstructured":"Maduna T, Audouard E, Demb\u00e9l\u00e9 D, Mouzaoui N, Reiss D, Massotte D, et al. Microglia express mu opioid receptor: insights from transcriptomics and fluorescent reporter mice. Front Psych. 2019;9:726.","journal-title":"Front Psych"},{"issue":"12","key":"445_CR171","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/glia.23685","volume":"67","author":"MJ Maksoud","year":"2019","unstructured":"Maksoud MJ, Tellios V, An D, Xiang YY, Lu WY. Nitric oxide upregulates microglia phagocytosis and increases transient receptor potential vanilloid type 2 channel expression on the plasma membrane. Glia. 2019;67(12):2294\u2013311.","journal-title":"Glia"},{"issue":"2","key":"445_CR172","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","volume":"10","author":"F Martinon","year":"2002","unstructured":"Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-\u03b2. Mol Cell. 2002;10(2):417\u201326.","journal-title":"Mol Cell"},{"issue":"6","key":"445_CR173","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1124\/mol.111.071290","volume":"79","author":"AM Mart\u00edn-Moreno","year":"2011","unstructured":"Mart\u00edn-Moreno AM, Reigada D, Ram\u00edrez BG, Mechoulam R, Innamorato N, Cuadrado A, et al. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer\u2019s disease. Mol Pharmacol. 2011;79(6):964\u201373.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"445_CR174","doi-asserted-by":"publisher","first-page":"15292","DOI":"10.1038\/ncomms15292","volume":"8","author":"MC Marrone","year":"2017","unstructured":"Marrone MC, Morabito A, Giustizieri M, Chiurchi\u00f9 V, Leuti A, Mattioli M, et al. TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Nat Commun. 2017;8(1):15292.","journal-title":"Nat Commun"},{"issue":"6876","key":"445_CR175","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature719","volume":"416","author":"DD McKemy","year":"2002","unstructured":"McKemy DD, Neuhausser WM, Julius D. Identification of a cold receptor reveals a general role for TRP channels in thermosensation. Nature. 2002;416(6876):52\u20138.","journal-title":"Nature"},{"key":"445_CR176","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","volume":"49","author":"M Mecha","year":"2015","unstructured":"Mecha M, Feli\u00fa A, Carrillo-Salinas F, Rueda-Zubiaurre A, Ortega-Guti\u00e9rrez S, de Sola RG, et al. Endocannabinoids drive the acquisition of an alternative phenotype in microglia. Brain Behav Immun. 2015;49:233\u201345.","journal-title":"Brain Behav Immun"},{"key":"445_CR177","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.nbd.2013.06.016","volume":"59","author":"M Mecha","year":"2013","unstructured":"Mecha M, Feli\u00fa A, \u00cdnigo PM, Mestre L, Carrillo-Salinas F, Guaza C. Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors. Neurobiol Dis. 2013;59:141\u201350.","journal-title":"Neurobiol Dis"},{"issue":"7203","key":"445_CR178","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335.","journal-title":"Nature"},{"key":"445_CR179","doi-asserted-by":"publisher","first-page":"1183019","DOI":"10.3389\/fphar.2023.1183019","volume":"14","author":"A Mendiguren","year":"2023","unstructured":"Mendiguren A, Aostri E, Rodilla I, Pujana I, Noskova E, Pineda J. Cannabigerol modulates \u03b12-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat. Front Pharmacol. 2023;14:1183019.","journal-title":"Front Pharmacol"},{"key":"445_CR180","doi-asserted-by":"publisher","first-page":"425858","DOI":"10.3389\/fphar.2018.01365","volume":"9","author":"SA Millar","year":"2018","unstructured":"Millar SA, Stone NL, Yates AS, O\u2019Sullivan SE. A systematic review on the pharmacokinetics of cannabidiol in humans. Front Pharmacol. 2018;9:425858.","journal-title":"Front Pharmacol"},{"issue":"2","key":"445_CR181","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bbadis.2010.09.010","volume":"1812","author":"VE Miron","year":"2011","unstructured":"Miron VE, Kuhlmann T, Antel JP. Cells of the oligodendroglial lineage, myelination, and remyelination. Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease. 2011;1812(2):184\u201393.","journal-title":"Biochimica Et Biophysica Acta (BBA)-Molecular Basis of Disease"},{"key":"445_CR182","doi-asserted-by":"publisher","first-page":"107841","DOI":"10.1016\/j.parkreldis.2025.107841","volume":"135","author":"W Mitarnun","year":"2025","unstructured":"Mitarnun W, Kanjanarangsichai A, Junlaor P, Kongngern L, Mitarnun W, Pangwong W, et al. Cannabidiol and cognitive functions\/inflammatory markers in Parkinson\u2019s disease: a double-blind randomized controlled trial at Buriram Hospital (CBD-PD-BRH trial). Parkinsonism Relat Disord. 2025;135:107841.","journal-title":"Parkinsonism Relat Disord"},{"key":"445_CR183","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-94-024-1088-4_10","volume":"976","author":"Y Mizoguchi","year":"2017","unstructured":"Mizoguchi Y, Monji A. TRPC channels and brain inflammation. Transient Receptor Potential Canonical Channels and Brain Diseases. 2017;976:111\u201321.","journal-title":"Transient Receptor Potential Canonical Channels and Brain Diseases."},{"issue":"4","key":"445_CR184","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1089\/can.2023.0025","volume":"9","author":"E Moazen-Zadeh","year":"2024","unstructured":"Moazen-Zadeh E, Chisholm A, Bachi K, Hurd YL. Pharmacokinetics of cannabidiol: a systematic review and meta-regression analysis. Cannabis Cannabinoid Res. 2024;9(4):939\u201366.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"6","key":"445_CR185","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/brainsci7060063","volume":"7","author":"R Morigaki","year":"2017","unstructured":"Morigaki R, Goto S. Striatal vulnerability in Huntington\u2019s disease: neuroprotection versus neurotoxicity. Brain Sci Basel. 2017;7(6):63.","journal-title":"Brain Sci Basel"},{"issue":"6","key":"445_CR186","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0031-9422(98)00278-7","volume":"49","author":"S Morimoto","year":"1998","unstructured":"Morimoto S, Komatsu K, Taura F, Shoyama Y. Purification and characterization of cannabichromenic acid synthase from Cannabis sativa. Phytochemistry. 1998;49(6):1525\u20139.","journal-title":"Phytochemistry"},{"issue":"12","key":"445_CR187","doi-asserted-by":"publisher","first-page":"17435","DOI":"10.1007\/s00210-025-04347-w","volume":"398","author":"P Mousavi","year":"2025","unstructured":"Mousavi P, Emadzadeh M, Karimikhoshnoudian B, Sahraian MA, Ghaffari M, Shaygannejad V, et al. A randomized trial on efficacy of purified cannabidiol on spasticity in Multiple Sclerosis patients with gait problems: first report in Iran. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(12):17435\u201344.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"445_CR188","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","volume":"11","author":"C Muller","year":"2018","unstructured":"Muller C, Morales P, Reggio P. Cannabinoid ligands targeting TRP channels. Front Mol Neurosci. 2018;11:487.","journal-title":"Front Mol Neurosci"},{"issue":"8","key":"445_CR189","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/cells7080109","volume":"7","author":"W Nadolni","year":"2018","unstructured":"Nadolni W, Zierler S. The channel-kinase TRPM7 as novel regulator of immune system homeostasis. Cells. 2018;7(8):109.","journal-title":"Cells"},{"issue":"21","key":"445_CR190","doi-asserted-by":"publisher","first-page":"11460","DOI":"10.3390\/ijms222111460","volume":"22","author":"R Naert","year":"2021","unstructured":"Naert R, L\u00f3pez-Requena A, Talavera K. TRPA1 expression and pathophysiology in immune cells. Int J Mol Sci. 2021;22(21):11460.","journal-title":"Int J Mol Sci"},{"key":"445_CR191","doi-asserted-by":"publisher","first-page":"632","DOI":"10.3389\/fphar.2018.00632","volume":"9","author":"G Navarro","year":"2018","unstructured":"Navarro G, Varani K, Reyes-Resina I, S\u00e1nchez de Medina V, Rivas-Santisteban R, S\u00e1nchez-Carnerero Callado C, et al. Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1\u2013CB2 heteroreceptor complexes. Front Pharmacol. 2018;9:632.","journal-title":"Front Pharmacol"},{"issue":"2","key":"445_CR192","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s11481-020-09917-8","volume":"16","author":"JM Nichols","year":"2021","unstructured":"Nichols JM, Kummari E, Sherman J, Yang E-J, Dhital S, Gilfeather C, et al. CBD suppression of EAE is correlated with early inhibition of splenic IFN-\u03b3+ CD8+ T cells and modest inhibition of neuroinflammation. J Neuroimmune Pharmacol. 2021;16(2):346\u201362.","journal-title":"J Neuroimmune Pharmacol"},{"issue":"2","key":"445_CR193","doi-asserted-by":"publisher","first-page":"C195","DOI":"10.1152\/ajpcell.00365.2003","volume":"286","author":"B Nilius","year":"2004","unstructured":"Nilius B, Vriens J, Prenen J, Droogmans G, Voets T. TRPV4 calcium entry channel: a paradigm for gating diversity. Am J Physiol Cell Physiol. 2004;286(2):C195\u2013205.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"5726","key":"445_CR194","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1126\/science.1110647","volume":"308","author":"A Nimmerjahn","year":"2005","unstructured":"Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science. 2005;308(5726):1314\u20138.","journal-title":"Science"},{"issue":"17","key":"445_CR195","doi-asserted-by":"publisher","first-page":"e2012894118","DOI":"10.1073\/pnas.2012894118","volume":"118","author":"R Nishimoto","year":"2021","unstructured":"Nishimoto R, Derouiche S, Eto K, Deveci A, Kashio M, Kimori Y, et al. Thermosensitive TRPV4 channels mediate temperature-dependent microglia movement. Proc Natl Acad Sci. 2021;118(17):e2012894118.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"445_CR196","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4161\/chan.3.2.8609","volume":"3","author":"L Ohana","year":"2009","unstructured":"Ohana L, Newell EW, Stanley EF, Schlichter LC. The Ca2+ release-activated Ca2+ current (ICRAC) mediates store-operated Ca2+ entry in rat microglia. Channels Austin. 2009;3(2):129\u201339.","journal-title":"Channels Austin"},{"issue":"2","key":"445_CR197","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/bms.1200130206","volume":"13","author":"A Ohlsson","year":"1986","unstructured":"Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE. Single\u2010dose kinetics of deuterium\u2010labelled cannabidiol in man after smoking and intravenous administration. Biomed Environ Mass Spectrom. 1986;13(2):77\u201383.","journal-title":"Biomed Environ Mass Spectrom"},{"issue":"4","key":"445_CR198","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","volume":"362","author":"S Oka","year":"2007","unstructured":"Oka S, Nakajima K, Yamashita A, Kishimoto S, Sugiura T. Identification of GPR55 as a lysophosphatidylinositol receptor. Biochem Biophys Res Commun. 2007;362(4):928\u201334.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"445_CR199","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol. 2017;13(1):25\u201336.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"445_CR200","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0166-2236(96)01035-1","volume":"20","author":"LA O'Neill","year":"1997","unstructured":"O\u2019Neill LA, Kaltschmidt C. NF-kB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997;20(6):252\u20138.","journal-title":"Trends Neurosci"},{"key":"445_CR201","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.phytochem.2015.03.006","volume":"116","author":"C Onofri","year":"2015","unstructured":"Onofri C, de Meijer EP, Mandolino G. Sequence heterogeneity of cannabidiolic-and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype. Phytochemistry. 2015;116:57\u201368.","journal-title":"Phytochemistry"},{"issue":"7","key":"445_CR202","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nn.2341","volume":"12","author":"AG Orr","year":"2009","unstructured":"Orr AG, Orr AL, Li X-J, Gross RE, Traynelis SF. Adenosine A2A receptor mediates microglial process retraction. Nat Neurosci. 2009;12(7):872\u20138.","journal-title":"Nat Neurosci"},{"issue":"12","key":"445_CR203","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1111\/bph.13497","volume":"173","author":"SE O'Sullivan","year":"2016","unstructured":"O\u2019Sullivan SE. An update on PPAR activation by cannabinoids. Br J Pharmacol. 2016;173(12):1899\u2013910.","journal-title":"Br J Pharmacol"},{"issue":"17","key":"445_CR204","doi-asserted-by":"publisher","first-page":"4034","DOI":"10.1111\/bph.15155","volume":"177","author":"B Palomares","year":"2020","unstructured":"Palomares B, Garrido\u2010Rodriguez M, Gonzalo\u2010Consuegra C, G\u00f3mez\u2010Ca\u00f1as M, Saen\u2010oon S, Soliva R, et al. \u03949\u2010Tetrahydrocannabinolic acid alleviates collagen\u2010induced arthritis: role of PPAR\u03b3 and CB1 receptors. Br J Pharmacol. 2020;177(17):4034\u201354.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"445_CR205","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.phrs.2009.03.019","volume":"60","author":"R Pandey","year":"2009","unstructured":"Pandey R, Mousawy K, Nagarkatti M, Nagarkatti P. Endocannabinoids and immune regulation. Pharmacol Res. 2009;60(2):85\u201392.","journal-title":"Pharmacol Res"},{"issue":"9","key":"445_CR206","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/epi.17000","volume":"62","author":"AD Patel","year":"2021","unstructured":"Patel AD, Mazurkiewicz\u2010Be\u0142dzi\u0144ska M, Chin RF, Gil\u2010Nagel A, Gunning B, Halford JJ, et al. Long\u2010term safety and efficacy of add\u2010on cannabidiol in patients with Lennox\u2013Gastaut syndrome: results of a long\u2010term open\u2010label extension trial. Epilepsia. 2021;62(9):2228\u201339.","journal-title":"Epilepsia"},{"key":"445_CR207","doi-asserted-by":"publisher","first-page":"921493","DOI":"10.3389\/fphar.2022.921493","volume":"13","author":"SD Pennypacker","year":"2022","unstructured":"Pennypacker SD, Cunnane K, Cash MC, Romero-Sandoval EA. Potency and therapeutic THC and CBD ratios: US cannabis markets overshoot. Front Pharmacol. 2022;13:921493.","journal-title":"Front Pharmacol"},{"issue":"1","key":"445_CR208","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1016\/j.jss.2012.05.047","volume":"179","author":"M Peng","year":"2013","unstructured":"Peng M, Wang Y-L, Wang C-Y, Chen C. Dexmedetomidine attenuates lipopolysaccharide-induced proinflammatory response in primary microglia. J Surg Res. 2013;179(1):e219\u201325.","journal-title":"J Surg Res"},{"issue":"5","key":"445_CR209","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s13318-020-00624-6","volume":"45","author":"D Perkins","year":"2020","unstructured":"Perkins D, Butler J, Ong K, Nguyen T-H, Cox S, Francis B, et al. A phase 1, randomised, placebo-controlled, dose escalation study to investigate the safety, tolerability and pharmacokinetics of cannabidiol in fed healthy volunteers. Eur J Drug Metab Pharmacokinet. 2020;45(5):575\u201386.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"2","key":"445_CR210","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"R Pertwee","year":"2008","unstructured":"Pertwee R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949\u2010tetrahydrocannabinol, cannabidiol and \u03949\u2010tetrahydrocannabivarin. Br J Pharmacol. 2008;153(2):199\u2013215.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"445_CR211","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/j.febslet.2009.05.028","volume":"583","author":"M Pietr","year":"2009","unstructured":"Pietr M, Kozela E, Levy R, Rimmerman N, Lin YH, Stella N, et al. Differential changes in GPR55 during microglial cell activation. FEBS Lett. 2009;583(12):2071\u20136.","journal-title":"FEBS Lett"},{"issue":"23","key":"445_CR212","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1111\/bph.14019","volume":"174","author":"X Nadal","year":"2017","unstructured":"Nadal X, Del R\u00edo C, Casano S, Palomares B, Ferreiro\u2010Vera C, Navarrete C, et al. Tetrahydrocannabinolic acid is a potent PPAR\u03b3 agonist with neuroprotective activity. Br J Pharmacol. 2017;174(23):4263\u201376.","journal-title":"Br J Pharmacol"},{"issue":"11","key":"445_CR213","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D Piomelli","year":"2003","unstructured":"Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003;4(11):873\u201384.","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"445_CR214","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00210-005-1055-5","volume":"371","author":"TD Plant","year":"2005","unstructured":"Plant TD, Schaefer M. Receptor-operated cation channels formed by TRPC4 and TRPC5. Naunyn Schmiedebergs Arch Pharmacol. 2005;371(4):266\u201376.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"445_CR215","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1038\/s41467-021-23005-2","volume":"12","author":"W Qiao","year":"2021","unstructured":"Qiao W, Wong KH, Shen J, Wang W, Wu J, Li J, et al. TRPM7 kinase-mediated immunomodulation in macrophage plays a central role in magnesium ion-induced bone regeneration. Nat Commun. 2021;12(1):2885.","journal-title":"Nat Commun"},{"issue":"24","key":"445_CR216","doi-asserted-by":"publisher","first-page":"6231","DOI":"10.1523\/JNEUROSCI.0504-08.2008","volume":"28","author":"N Qin","year":"2008","unstructured":"Qin N, Neeper MP, Liu Y, Hutchinson TL, Lubin ML, Flores CM. TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci. 2008;28(24):6231\u20138.","journal-title":"J Neurosci"},{"issue":"1","key":"445_CR217","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12865-023-00549-0","volume":"24","author":"A Radhakrishnan","year":"2023","unstructured":"Radhakrishnan A, Mukherjee T, Mahish C, Kumar PS, Goswami C, Chattopadhyay S. TRPA1 activation and Hsp90 inhibition synergistically downregulate macrophage activation and inflammatory responses in vitro. BMC Immunol. 2023;24(1):16.","journal-title":"BMC Immunol"},{"issue":"24","key":"445_CR218","doi-asserted-by":"publisher","first-page":"17500","DOI":"10.3390\/ijms242417500","volume":"24","author":"I Ra\u00efch","year":"2023","unstructured":"Ra\u00efch I, Lillo J, Ferreiro-Vera C, S\u00e1nchez de Medina V, Navarro G, Franco R. Cannabidiol at nanomolar concentrations negatively affects signaling through the adenosine A2A receptor. Int J Mol Sci. 2023;24(24):17500.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"445_CR219","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13195-025-01756-0","volume":"17","author":"I Ra\u00efch","year":"2025","unstructured":"Ra\u00efch I, Lillo J, Rebassa JB, Gri\u00f1\u00e1n-Ferr\u00e9 C, Bellver-Sanchis A, Reyes-Resina I, et al. Cannabidiol as a multifaceted therapeutic agent: mitigating Alzheimer\u2019s disease pathology and enhancing cognitive function. Alzheimer\u2019s Res Ther. 2025;17(1):109.","journal-title":"Alzheimer's Res Ther"},{"key":"445_CR220","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neuroscience.2015.01.030","volume":"290","author":"A Rahimi","year":"2015","unstructured":"Rahimi A, Faizi M, Talebi F, Noorbakhsh F, Kahrizi F, Naderi N. Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL\/6 mice. Neuroscience. 2015;290:279\u201387.","journal-title":"Neuroscience"},{"issue":"6301","key":"445_CR221","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353(6301):777\u201383.","journal-title":"Science"},{"issue":"5","key":"445_CR222","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.immuni.2009.09.010","volume":"31","author":"RM Ransohoff","year":"2009","unstructured":"Ransohoff RM. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity. 2009;31(5):711\u201321.","journal-title":"Immunity"},{"issue":"8","key":"445_CR223","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nn.4338","volume":"19","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19(8):987\u201391.","journal-title":"Nat Neurosci"},{"issue":"6","key":"445_CR224","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1002\/glia.23979","volume":"69","author":"SN Redmon","year":"2021","unstructured":"Redmon SN, Yarishkin O, Lakk M, Jo A, Mustafi\u0107 E, Tvrdik P, et al. TRPV4 channels mediate the mechanoresponse in retinal microglia. Glia. 2021;69(6):1563\u201382.","journal-title":"Glia"},{"issue":"2","key":"445_CR225","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","volume":"378","author":"DS Reich","year":"2018","unstructured":"Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl J Med. 2018;378(2):169\u201380.","journal-title":"N Engl J Med"},{"issue":"1","key":"445_CR226","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jnr.24626","volume":"100","author":"D Reiss","year":"2022","unstructured":"Reiss D, Maduna T, Maurin H, Audouard E, Gaveriaux\u2010Ruff C. Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice. J Neurosci Res. 2022;100(1):203\u201319.","journal-title":"J Neurosci Res"},{"issue":"2","key":"445_CR227","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00401-011-0840-0","volume":"122","author":"R Reynolds","year":"2011","unstructured":"Reynolds R, Roncaroli F, Nicholas R, Radotra B, Gveric D, Howell O. The neuropathological basis of clinical progression in multiple sclerosis. Acta Neuropathol. 2011;122(2):155\u201370.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"445_CR228","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1212\/NXI.0000000000000443","volume":"5","author":"E Rissanen","year":"2018","unstructured":"Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R, et al. Microglial activation, white matter tract damage, and disability in MS. Neurol Neuroimmunol Neuroinflamm. 2018;5(3):e443.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"445_CR229","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/bph.12120","volume":"169","author":"B Romano","year":"2013","unstructured":"Romano B, Borrelli F, Fasolino I, Capasso R, Piscitelli F, Cascio M, et al. The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis. Br J Pharmacol. 2013;169(1):213\u201329.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"445_CR230","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tips.2008.12.004","volume":"30","author":"RA Ross","year":"2009","unstructured":"Ross RA. The enigmatic pharmacology of GPR55. Trends Pharmacol Sci. 2009;30(3):156\u201363.","journal-title":"Trends Pharmacol Sci"},{"issue":"7","key":"445_CR231","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","volume":"152","author":"E Ryberg","year":"2007","unstructured":"Ryberg E, Larsson N, Sj\u00f6gren S, Hjorth S, Hermansson NO, Leonova J, et al. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol. 2007;152(7):1092\u2013101.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"445_CR232","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.2174\/1570159X19666211201094608","volume":"20","author":"J Saba","year":"2022","unstructured":"Saba J, Couselo FL, Bruno J, Carniglia L, Durand D, Lasaga M, et al. Neuroinflammation in Huntington\u2019s disease: a starring role for astrocyte and microglia. Curr Neuropharmacol. 2022;20(6):1116\u201343.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"445_CR233","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12967-021-02891-6","volume":"19","author":"AH Sadaka","year":"2021","unstructured":"Sadaka AH, Ozuna AG, Ortiz RJ, Kulkarni P, Johnson CT, Bradshaw HB, et al. Cannabidiol has a unique effect on global brain activity: a pharmacological, functional MRI study in awake mice. J Transl Med. 2021;19(1):220.","journal-title":"J Transl Med"},{"issue":"6","key":"445_CR234","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1017\/S1355617721000114","volume":"27","author":"KA Sagar","year":"2021","unstructured":"Sagar KA, Dahlgren MK, Lambros AM, Smith RT, El-Abboud C, Gruber SA. An observational, longitudinal study of cognition in medical cannabis patients over the course of 12 months of treatment: preliminary results. J Int Neuropsychol Soc. 2021;27(6):648\u201360.","journal-title":"J Int Neuropsychol Soc"},{"issue":"4","key":"445_CR235","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1460-9568.2007.05717.x","volume":"26","author":"O Sagredo","year":"2007","unstructured":"Sagredo O, Ramos JA, Decio A, Mechoulam R, Fern\u00e1ndez\u2010Ruiz J. Cannabidiol reduced the striatal atrophy caused 3\u2010nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. Eur J Neurosci. 2007;26(4):843\u201351.","journal-title":"Eur J Neurosci"},{"issue":"3","key":"445_CR236","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41423-025-01257-y","volume":"22","author":"S Saito","year":"2025","unstructured":"Saito S, Cao D-Y, Bernstein EA, Shibata T, Jones AE, Rios A, et al. Peroxisome proliferator-activated receptor alpha is an essential factor in enhanced macrophage immune function induced by angiotensin-converting enzyme. Cell Mol Immunol. 2025;22(3):243\u201359.","journal-title":"Cell Mol Immunol"},{"key":"445_CR237","doi-asserted-by":"crossref","unstructured":"Sajjadian M, Kashani IR, Pasbakhsh P, Hassani M, Omidi A, Takzare N, et al. Protective effects of cannabidiol on cuprizone-induced demyelination in C57BL\/6 mice. J Contemp Med Sci. 2017;3(11):278\u201383.","DOI":"10.22317\/jcms.09201707"},{"issue":"1","key":"445_CR238","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12974-018-1362-7","volume":"15","author":"SW Saliba","year":"2018","unstructured":"Saliba SW, Jauch H, Gargouri B, Keil A, Hurrle T, Volz N, et al. Anti-neuroinflammatory effects of GPR55 antagonists in LPS-activated primary microglial cells. J Neuroinflammation. 2018;15(1):322.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"445_CR239","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1017\/neu.2023.30","volume":"36","author":"N S\u00e1nchez-Fern\u00e1ndez","year":"2024","unstructured":"S\u00e1nchez-Fern\u00e1ndez N, G\u00f3mez-Acero L, Sarasola LI, Argerich J, Chevign\u00e9 A, Jacobson KA, et al. Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells. Acta Neuropsychiatrica. 2024;36(5):320\u20134.","journal-title":"Acta Neuropsychiatrica"},{"issue":"1","key":"445_CR240","first-page":"465694","volume":"2014","author":"AR Santiago","year":"2014","unstructured":"Santiago AR, Baptista FI, Santos PF, Crist\u00f3v\u00e3o G, Ambr\u00f3sio AF, Cunha RA, et al. Role of microglia adenosine A2A receptors in retinal and brain neurodegenerative diseases. Mediators Inflamm. 2014;2014(1):465694.","journal-title":"Mediators Inflamm"},{"issue":"7","key":"445_CR241","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1167\/iovs.07-1355","volume":"49","author":"RM Sappington","year":"2008","unstructured":"Sappington RM, Calkins DJ. Contribution of TRPV1 to microglia-derived IL-6 and NF\u03baB translocation with elevated hydrostatic pressure. Invest Ophthalmol vis Sci. 2008;49(7):3004\u201317.","journal-title":"Invest Ophthalmol vis Sci"},{"issue":"1","key":"445_CR242","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.immuni.2017.11.026","volume":"48","author":"MS Schappe","year":"2018","unstructured":"Schappe MS, Szteyn K, Stremska ME, Mendu SK, Downs TK, Seegren PV, et al. Chanzyme TRPM7 mediates the Ca2+ influx essential for lipopolysaccharide-induced toll-like receptor 4 endocytosis and macrophage activation. Immunity. 2018;48(1):59-74.e5.","journal-title":"Immunity"},{"issue":"10284","key":"445_CR243","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. Alzheimer\u2019s disease. The Lancet. 2021;397(10284):1577\u201390.","journal-title":"The Lancet"},{"issue":"s3","key":"445_CR244","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3233\/JAD-2006-9S312","volume":"9","author":"SW Scheff","year":"2006","unstructured":"Scheff SW, Price DA. Alzheimer\u2019s disease-related alterations in synaptic density: neocortex and hippocampus. J Alzheimers Dis. 2006;9(s3):101\u201315.","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"445_CR245","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.freeradbiomed.2012.02.032","volume":"52","author":"CI Schnegg","year":"2012","unstructured":"Schnegg CI, Kooshki M, Hsu F-C, Sui G, Robbins ME. PPAR\u03b4 prevents radiation-induced proinflammatory responses in microglia via transrepression of NF-\u03baB and inhibition of the PKC\u03b1\/MEK1\/2\/ERK1\/2\/AP-1 pathway. Free Radic Biol Med. 2012;52(9):1734\u201343.","journal-title":"Free Radic Biol Med"},{"key":"445_CR246","doi-asserted-by":"publisher","first-page":"1328885","DOI":"10.3389\/fphar.2023.1328885","volume":"14","author":"M Schouten","year":"2024","unstructured":"Schouten M, Dalle S, Mantini D, Koppo K. Cannabidiol and brain function: current knowledge and future perspectives. Front Pharmacol. 2024;14:1328885.","journal-title":"Front Pharmacol"},{"issue":"10","key":"445_CR247","doi-asserted-by":"publisher","first-page":"e920","DOI":"10.1038\/tp.2016.195","volume":"6","author":"P Seeman","year":"2016","unstructured":"Seeman P. Cannabidiol is a partial agonist at dopamine D2High receptors, predicting its antipsychotic clinical dose. Transl Psychiatry. 2016;6(10):e920.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"445_CR248","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbr.2008.02.016","volume":"192","author":"DJ Selkoe","year":"2008","unstructured":"Selkoe DJ. Soluble oligomers of the amyloid \u03b2-protein impair synaptic plasticity and behavior. Behav Brain Res. 2008;192(1):106\u201313.","journal-title":"Behav Brain Res"},{"issue":"3","key":"445_CR249","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pharmthera.2010.02.004","volume":"126","author":"H Sharir","year":"2010","unstructured":"Sharir H, Abood ME. Pharmacological characterization of GPR55, a putative cannabinoid receptor. Pharmacol Ther. 2010;126(3):301\u201313.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"445_CR250","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41531-024-00780-5","volume":"10","author":"C Shi","year":"2024","unstructured":"Shi C, Ma D, Li M, Wang Z, Hao C, Liang Y, et al. Identifying potential causal effects of Parkinson\u2019s disease: a polygenic risk score-based phenome-wide association and Mendelian randomization study in UK Biobank. Npj Park Dis. 2024;10(1):166.","journal-title":"Npj Park Dis"},{"issue":"13","key":"445_CR251","doi-asserted-by":"publisher","first-page":"4601","DOI":"10.1523\/JNEUROSCI.5830-09.2010","volume":"30","author":"K Shibasaki","year":"2010","unstructured":"Shibasaki K, Murayama N, Ono K, Ishizaki Y, Tominaga M. TRPV2 enhances axon outgrowth through its activation by membrane stretch in developing sensory and motor neurons. J Neurosci. 2010;30(13):4601\u201312.","journal-title":"J Neurosci"},{"key":"445_CR252","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbrc.2023.09.078","volume":"682","author":"D Shikha","year":"2023","unstructured":"Shikha D, Mahish C, Sing R, Chattopadhyay S, Goswami C. Modulation of TRPM8 alters the phagocytic activity of microglia and induces changes in sub-cellular organelle functions. Biochem Biophys Res Commun. 2023;682:56\u201363.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"445_CR253","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.bbrc.2020.10.021","volume":"533","author":"SH Shrader","year":"2020","unstructured":"Shrader SH, Tong Y-G, Duff MB, Freedman JH, Song Z-H. Involvement of dopamine receptor in the actions of non-psychoactive phytocannabinoids. Biochem Biophys Res Commun. 2020;533(4):1366\u201370.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"445_CR254","doi-asserted-by":"publisher","first-page":"e106087","DOI":"10.1371\/journal.pone.0106087","volume":"9","author":"T Siddiqui","year":"2014","unstructured":"Siddiqui T, Lively S, Ferreira R, Wong R, Schlichter LC. Expression and contributions of TRPM7 and KCa2. 3\/SK3 channels to the increased migration and invasion of microglia in anti-inflammatory activation states. PLoS ONE. 2014;9(8):e106087.","journal-title":"PLoS ONE"},{"key":"445_CR255","doi-asserted-by":"publisher","first-page":"106031","DOI":"10.1016\/j.neuint.2025.106031","volume":"189","author":"R Sing","year":"2025","unstructured":"Sing R, Shikha D, Goswami C. TRPM8 modulation alters uptake of Transferrin-mediated Fe3+, mitochondrial Fe2+ and intracellular Ca2+-levels in microglia. Neurochem Int. 2025;189:106031.","journal-title":"Neurochem Int"},{"key":"445_CR256","doi-asserted-by":"publisher","first-page":"1628872","DOI":"10.3389\/fimmu.2025.1628872","volume":"16","author":"C Skeete","year":"2025","unstructured":"Skeete C, Sgambettera G, Gojanovich AD, He X, Bryant D, Yang M, et al. Mu opioid receptor activation in microglia enhances HIV-1 infection and HIV-infection-induced inflammatory responses. Front Immunol. 2025;16:1628872.","journal-title":"Front Immunol"},{"issue":"2","key":"445_CR257","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0026-895X(25)10254-X","volume":"48","author":"DM Slipetz","year":"1995","unstructured":"Slipetz DM, O\u2019Neill GP, Favreau L, Dufresne C, Gallant M, Gareau Y, et al. Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol. 1995;48(2):352\u201361.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"445_CR258","first-page":"144","volume":"36","author":"E Small","year":"1973","unstructured":"Small E, Beckstead H. Common cannabinoid phenotypes in 350 stocks of Cannabis. Lloydia. 1973;36(2):144\u201365.","journal-title":"Lloydia"},{"issue":"5","key":"445_CR259","doi-asserted-by":"publisher","first-page":"e0267498","DOI":"10.1371\/journal.pone.0267498","volume":"17","author":"CJ Smith","year":"2022","unstructured":"Smith CJ, Vergara D, Keegan B, Jikomes N. The phytochemical diversity of commercial Cannabis in the United States. PLoS ONE. 2022;17(5):e0267498.","journal-title":"PLoS ONE"},{"issue":"1","key":"445_CR260","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainresbull.2011.10.004","volume":"87","author":"JA Smith","year":"2012","unstructured":"Smith JA, Das A, Ray SK, Banik NL. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87(1):10\u201320.","journal-title":"Brain Res Bull"},{"issue":"1","key":"445_CR261","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1038\/ncomms13958","volume":"8","author":"M Soethoudt","year":"2017","unstructured":"Soethoudt M, Grether U, Fingerle J, Grim TW, Fezza F, De Petrocellis L, et al. Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity. Nat Commun. 2017;8(1):13958.","journal-title":"Nat Commun"},{"key":"445_CR262","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","volume":"56","author":"N Stella","year":"2009","unstructured":"Stella N. Endocannabinoid signaling in microglial cells. Neuropharmacology. 2009;56:244\u201353.","journal-title":"Neuropharmacology"},{"issue":"9","key":"445_CR263","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/glia.20983","volume":"58","author":"N Stella","year":"2010","unstructured":"Stella N. Cannabinoid and cannabinoid\u2010like receptors in microglia, astrocytes, and astrocytomas. Glia. 2010;58(9):1017\u201330.","journal-title":"Glia"},{"issue":"2","key":"445_CR264","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2174\/1570159X15666170424120802","volume":"16","author":"MV Storozhuk","year":"2018","unstructured":"Storozhuk MV, Zholos AV. TRP channels as novel targets for endogenous ligands: focus on endocannabinoids and nociceptive signalling. Curr Neuropharmacol. 2018;16(2):137\u201350.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"445_CR265","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1038\/s41598-023-33507-2","volume":"13","author":"S Suzuki","year":"2023","unstructured":"Suzuki S, Fleig A, Penner R. CBGA ameliorates inflammation and fibrosis in nephropathy. Sci Rep. 2023;13(1):6341.","journal-title":"Sci Rep"},{"issue":"1","key":"445_CR266","doi-asserted-by":"publisher","first-page":"zqad069","DOI":"10.1093\/function\/zqad069","volume":"5","author":"S Suzuki","year":"2024","unstructured":"Suzuki S, Wakano C, Monteilh-Zoller MK, Cullen AJ, Fleig A, Penner R. Cannabigerolic Acid (CBGA) inhibits the TRPM7 ion channel through its kinase domain. Function. 2024;5(1):zqad069.","journal-title":"Function"},{"issue":"3","key":"445_CR267","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018;14(3):133\u201350.","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"445_CR268","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s42238-021-00062-4","volume":"3","author":"MN Tahir","year":"2021","unstructured":"Tahir MN, Raz FS, Rondeau-Gagn\u00e9 S, Trant JF. The biosynthesis of the cannabinoids. J Cannabis Res. 2021;3(1):7.","journal-title":"J Cannabis Res"},{"issue":"2\u20133","key":"445_CR269","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brainresbull.2006.10.029","volume":"72","author":"YF Tai","year":"2007","unstructured":"Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, et al. Imaging microglial activation in Huntington\u2019s disease. Brain Res Bull. 2007;72(2\u20133):148\u201351.","journal-title":"Brain Res Bull"},{"key":"445_CR270","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fneur.2020.00087","volume":"11","author":"M Tanaka","year":"2020","unstructured":"Tanaka M, Sackett S, Zhang Y. Endocannabinoid modulation of microglial phenotypes in neuropathology. Front Neurol. 2020;11:87.","journal-title":"Front Neurol"},{"issue":"3\u20134","key":"445_CR271","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000503452","volume":"105","author":"L Tao","year":"2020","unstructured":"Tao L, Guo G, Qi Y, Xiong Y, Ma X, Wu N, et al. Inhibition of canonical transient receptor potential 5 channels polarizes macrophages to an M1 phenotype. Pharmacology. 2020;105(3\u20134):202\u20138.","journal-title":"Pharmacology"},{"key":"445_CR272","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbi.2016.05.020","volume":"58","author":"Y Tao","year":"2016","unstructured":"Tao Y, Li L, Jiang B, Feng Z, Yang L, Tang J, et al. Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1\/M2 polarization through the cAMP\/PKA pathway in an experimental GMH rat model. Brain Behav Immun. 2016;58:118\u201329.","journal-title":"Brain Behav Immun"},{"issue":"38","key":"445_CR273","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.1021\/ja00143a024","volume":"117","author":"F Taura","year":"1995","unstructured":"Taura F, Morimoto S, Shoyama Y, Mechoulam R. First direct evidence for the mechanism of. DELTA. 1-tetrahydrocannabinolic acid biosynthesis. J Am Chem Soc. 1995;117(38):9766\u20137.","journal-title":"J Am Chem Soc"},{"issue":"16","key":"445_CR274","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1016\/j.febslet.2007.05.043","volume":"581","author":"F Taura","year":"2007","unstructured":"Taura F, Sirikantaramas S, Shoyama Y, Yoshikai K, Shoyama Y, Morimoto S. Cannabidiolic-acid synthase, the chemotype-determining enzyme in the fiber-type Cannabis sativa. FEBS Lett. 2007;581(16):2929\u201334.","journal-title":"FEBS Lett"},{"issue":"4","key":"445_CR275","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3390\/pharmaceutics10040269","volume":"10","author":"DM Teleanu","year":"2018","unstructured":"Teleanu DM, Chircov C, Grumezescu AM, Volceanov A, Teleanu RI. Blood-brain delivery methods using nanotechnology. Pharmaceutics. 2018;10(4):269.","journal-title":"Pharmaceutics"},{"issue":"5","key":"445_CR276","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","volume":"150","author":"A Thomas","year":"2007","unstructured":"Thomas A, Baillie G, Phillips A, Razdan R, Ross RA, Pertwee R. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro. Br J Pharmacol. 2007;150(5):613\u201323.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"445_CR277","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.bjp.0706414","volume":"146","author":"A Thomas","year":"2005","unstructured":"Thomas A, Stevenson LA, Wease KN, Price MR, Baillie G, Ross RA, et al. Evidence that the plant cannabinoid \u03949-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist. Br J Pharmacol. 2005;146(7):917.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"445_CR278","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"1","key":"445_CR279","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41467-024-55808-4","volume":"16","author":"TS Thorsen","year":"2025","unstructured":"Thorsen TS, Kulkarni Y, Sykes DA, B\u00f8ggild A, Drace T, Hompluem P, et al. Structural basis of THC analog activity at the Cannabinoid 1 receptor. Nat Commun. 2025;16(1):486.","journal-title":"Nat Commun"},{"issue":"1","key":"445_CR280","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","volume":"45","author":"C Titus","year":"2024","unstructured":"Titus C, Hoque MT, Bendayan R. PPAR agonists for the treatment of neuroinflammatory diseases. Trends Pharmacol Sci. 2024;45(1):9\u201323.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"445_CR281","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/bmb\/ldad035","volume":"149","author":"L Trevisan","year":"2024","unstructured":"Trevisan L, Gaudio A, Monfrini E, Avanzino L, Di Fonzo A, Mandich P. Genetics in Parkinson\u2019s disease, state-of-the-art and future perspectives. Br Med Bull. 2024;149(1):60\u201371.","journal-title":"Br Med Bull"},{"issue":"33","key":"445_CR282","doi-asserted-by":"publisher","first-page":"13519","DOI":"10.1073\/pnas.0705923104","volume":"104","author":"M Trevisani","year":"2007","unstructured":"Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci. 2007;104(33):13519\u201324.","journal-title":"Proc Natl Acad Sci"},{"issue":"7","key":"445_CR283","doi-asserted-by":"publisher","first-page":"3845","DOI":"10.3390\/ijms25073845","volume":"25","author":"H Tong","year":"2024","unstructured":"Tong H, Yang T, Xu S, Li X, Liu L, Zhou G, et al. Huntington\u2019s disease: complex pathogenesis and therapeutic strategies. Int J Mol Sci. 2024;25(7):3845.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"445_CR284","doi-asserted-by":"publisher","first-page":"e70241","DOI":"10.1002\/csc2.70241","volume":"66","author":"A Torres","year":"2026","unstructured":"Torres A, King C, Pauli CS, Blank T, Land DP, DeCesare K, et al. Cannabichromene variation in hemp cultivars. Crop Sci. 2026;66(2):e70241.","journal-title":"Crop Sci"},{"issue":"23","key":"445_CR285","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1111\/bph.14815","volume":"176","author":"M Udoh","year":"2019","unstructured":"Udoh M, Santiago M, Devenish S, McGregor IS, Connor M. Cannabichromene is a cannabinoid CB2 receptor agonist. Br J Pharmacol. 2019;176(23):4537\u201347.","journal-title":"Br J Pharmacol"},{"issue":"1","key":"445_CR286","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1089\/can.2023.0212","volume":"10","author":"M Udoh","year":"2025","unstructured":"Udoh M, Santiago M, Haneef S, Rodger A, Marlowe CK, Barr PJ, et al. Activation of CB2 Receptors by (\u2212)-Cannabichromene but Not (+)-Cannabichromene. Cannabis Cannabinoid Res. 2025;10(1):e94\u2013101.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"445_CR287","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13311-014-0304-z","volume":"12","author":"S Valdeolivas","year":"2015","unstructured":"Valdeolivas S, Navarrete C, Cantarero I, Bellido ML, Mu\u00f1oz E, Sagredo O. Neuroprotective properties of cannabigerol in Huntington\u2019s disease: studies in R6\/2 mice and 3-nitropropionate-lesioned mice. Neurotherapeutics. 2015;12(1):185\u201399.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"445_CR288","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/s41467-019-08976-7","volume":"10","author":"M van der Poel","year":"2019","unstructured":"van der Poel M, Ulas T, Mizee MR, Hsiao C-C, Miedema SS, Adelia n, et al. Transcriptional profiling of human microglia reveals grey\u2013white matter heterogeneity and Multiple Sclerosis-associated changes. Nat Commun. 2019;10(1):1139.","journal-title":"Nat Commun"},{"key":"445_CR289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","volume":"60","author":"A Varatharaj","year":"2017","unstructured":"Varatharaj A, Galea I. The blood-brain barrier in systemic inflammation. Brain Behav Immun. 2017;60:1\u201312.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"445_CR290","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1017\/S1041610224000516","volume":"36","author":"L Velayudhan","year":"2024","unstructured":"Velayudhan L, Dugonjic M, Pisani S, Harborow L, Aarsland D, Bassett P, et al. Cannabidiol for behavior symptoms in Alzheimer\u2019s disease (CANBiS-AD): a randomized, double-blind, placebo-controlled trial. Int Psychogeriatr. 2024;36(12):1270\u20132.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"445_CR291","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1146\/annurev.biochem.75.103004.142819","volume":"76","author":"K Venkatachalam","year":"2007","unstructured":"Venkatachalam K, Montell C. TRP channels. Annu Rev Biochem. 2007;76(1):387\u2013417.","journal-title":"Annu Rev Biochem"},{"issue":"6","key":"445_CR292","doi-asserted-by":"publisher","first-page":"plz074","DOI":"10.1093\/aobpla\/plz074","volume":"11","author":"D Vergara","year":"2019","unstructured":"Vergara D, Huscher EL, Keepers KG, Givens RM, Cizek CG, Torres A, et al. Gene copy number is associated with phytochemistry in Cannabis sativa. AoB Plants. 2019;11(6):plz074.","journal-title":"AoB Plants."},{"issue":"1","key":"445_CR293","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/ptr.8369","volume":"39","author":"RM Vitale","year":"2025","unstructured":"Vitale RM, Morace AM, D\u2019Errico A, Ricciardi F, Fusco A, Boccella S, et al. Identification of Cannabidiolic and Cannabigerolic Acids as MTDL AChE, BuChE, and BACE-1 Inhibitors Against Alzheimer\u2019s Disease by In Silico, In Vitro, and In Vivo Studies. Phytother Res. 2025;39(1):233\u201345.","journal-title":"Phytother Res"},{"issue":"9557","key":"445_CR294","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0140-6736(07)60111-1","volume":"369","author":"FO Walker","year":"2007","unstructured":"Walker FO. Huntington\u2019s disease. The Lancet. 2007;369(9557):218\u201328.","journal-title":"The Lancet"},{"issue":"1","key":"445_CR295","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/receptors1010002","volume":"1","author":"KB Walsh","year":"2022","unstructured":"Walsh KB, Holmes AE. Pharmacology of minor cannabinoids at the cannabinoid CB1 receptor: isomer-and ligand-dependent antagonism by tetrahydrocannabivarin. Receptors. 2022;1(1):3\u201312.","journal-title":"Receptors"},{"issue":"4","key":"445_CR296","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1523\/JNEUROSCI.23-04-01398.2003","volume":"23","author":"L Walter","year":"2003","unstructured":"Walter L, Franklin A, Witting A, Wade C, Xie Y, Kunos G, et al. Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci. 2003;23(4):1398\u2013405.","journal-title":"J Neurosci"},{"issue":"6","key":"445_CR297","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41419-019-1612-3","volume":"10","author":"Z Wang","year":"2019","unstructured":"Wang Z, Zhou L, An D, Xu W, Wu C, Sha S, et al. TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice. Cell Death Dis. 2019;10(6):386.","journal-title":"Cell Death Dis"},{"issue":"14","key":"445_CR298","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, et al. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Mult Scler J. 2020;26(14):1816\u201321.","journal-title":"Mult Scler J"},{"key":"445_CR299","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neuroscience.2022.06.036","volume":"498","author":"L Wang","year":"2022","unstructured":"Wang L, Wu X, Yang G, Hu N, Zhao Z, Zhao L, et al. Cannabidiol alleviates the damage to dopaminergic neurons in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson\u2019s disease mice via regulating neuronal apoptosis and neuroinflammation. Neuroscience. 2022a;498:64\u201372.","journal-title":"Neuroscience"},{"key":"445_CR300","doi-asserted-by":"publisher","first-page":"929222","DOI":"10.3389\/fimmu.2022.929222","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Lin C, Wu S, Zhang T, Wang Y, Jiang Y. Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia. Front Immunol. 2022b;13:929222.","journal-title":"Front Immunol"},{"issue":"6947","key":"445_CR301","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/nature01807","volume":"424","author":"H Watanabe","year":"2003","unstructured":"Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature. 2003;424(6947):434\u20138.","journal-title":"Nature"},{"key":"445_CR302","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3389\/fpls.2018.01510","volume":"9","author":"MT Welling","year":"2018","unstructured":"Welling MT, Liu L, Raymond CA, Ansari O, King GJ. Developmental plasticity of the major alkyl cannabinoid chemotypes in a diverse Cannabis genetic resource collection. Front Plant Sci. 2018;9:1510.","journal-title":"Front Plant Sci"},{"issue":"1","key":"445_CR303","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-022-02073-5","volume":"11","author":"A Wieghorst","year":"2022","unstructured":"Wieghorst A, Roessler KK, Hendricks O, Andersen TE. The effect of medical cannabis on cognitive functions: a systematic review. Syst Rev. 2022;11(1):210.","journal-title":"Syst Rev"},{"issue":"11","key":"445_CR304","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1038\/s41591-023-02566-3","volume":"29","author":"DK Wilton","year":"2023","unstructured":"Wilton DK, Mastro K, Heller MD, Gergits FW, Willing CR, Fahey JB, et al. Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington\u2019s disease. Nat Med. 2023;29(11):2866\u201384.","journal-title":"Nat Med"},{"issue":"5","key":"445_CR305","doi-asserted-by":"publisher","first-page":"e0251677","DOI":"10.1371\/journal.pone.0251677","volume":"16","author":"J Wu","year":"2021","unstructured":"Wu J, Chen N, Liu Y, Godlewski G, Kaplan HJ, Shrader SH, et al. Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia. PLoS ONE. 2021;16(5):e0251677.","journal-title":"PLoS ONE"},{"key":"445_CR306","doi-asserted-by":"publisher","first-page":"1187890","DOI":"10.3389\/fimmu.2023.1187890","volume":"14","author":"J Wu","year":"2023","unstructured":"Wu J, Li Z, Deng Y, Lu X, Luo C, Mu X, et al. Function of TRP channels in monocytes\/macrophages. Front Immunol. 2023;14:1187890.","journal-title":"Front Immunol"},{"issue":"2","key":"445_CR307","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/WNR.0000000000001862","volume":"34","author":"M Xia","year":"2023","unstructured":"Xia M, Chen Y-J, Chen B, Ru X, Wang J, Lin J, et al. Knockout of transient receptor potential ankyrin 1 (TRPA1) modulates the glial phenotype and alleviates perihematomal neuroinflammation after intracerebral hemorrhage in mice via MAPK\/NF-\u03baB signaling. NeuroReport. 2023;34(2):81\u201392.","journal-title":"NeuroReport"},{"key":"445_CR308","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.bbi.2024.05.016","volume":"119","author":"G Xie","year":"2024","unstructured":"Xie G, Gao X, Guo Q, Liang H, Yao L, Li W, et al. Cannabidiol ameliorates PTSD-like symptoms by inhibiting neuroinflammation through its action on CB2 receptors in the brain of male mice. Brain Behav Immun. 2024;119:945\u201364.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"445_CR309","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.3390\/ijms23105367","volume":"23","author":"S Yang","year":"2022","unstructured":"Yang S, Du Y, Zhao X, Tang Q, Su W, Hu Y, et al. Cannabidiol enhances microglial beta-amyloid peptide phagocytosis and clearance via vanilloid family type 2 channel activation. Int J Mol Sci. 2022;23(10):5367.","journal-title":"Int J Mol Sci"},{"key":"445_CR310","doi-asserted-by":"publisher","first-page":"1093925","DOI":"10.3389\/fphys.2023.1093925","volume":"14","author":"K Yao","year":"2023","unstructured":"Yao K, Dou B, Zhang Y, Chen Z, Li Y, Fan Z, et al. Inflammation\u2014the role of TRPA1 channel. Front Physiol. 2023;14:1093925.","journal-title":"Front Physiol"},{"issue":"1","key":"445_CR311","doi-asserted-by":"publisher","first-page":"e0191070","DOI":"10.1371\/journal.pone.0191070","volume":"13","author":"C-H Yeh","year":"2018","unstructured":"Yeh C-H, Hsieh L-P, Lin M-C, Wei T-S, Lin H-C, Chang C-C, et al. Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia. PLoS ONE. 2018;13(1):e0191070.","journal-title":"PLoS ONE"},{"issue":"6430","key":"445_CR312","doi-asserted-by":"publisher","first-page":"eaav9334","DOI":"10.1126\/science.aav9334","volume":"363","author":"Y Yin","year":"2019","unstructured":"Yin Y, Le SC, Hsu AL, Borgnia MJ, Yang H, Lee S-Y. Structural basis of cooling agent and lipid sensing by the cold-activated TRPM8 channel. Science. 2019;363(6430):eaav9334.","journal-title":"Science"},{"issue":"6616","key":"445_CR313","doi-asserted-by":"publisher","first-page":"eadd1268","DOI":"10.1126\/science.add1268","volume":"378","author":"Y Yin","year":"2022","unstructured":"Yin Y, Zhang F, Feng S, Butay KJ, Borgnia MJ, Im W, et al. Activation mechanism of the mouse cold-sensing TRPM8 channel by cooling agonist and PIP2. Science. 2022;378(6616):eadd1268.","journal-title":"Science"},{"issue":"1","key":"445_CR314","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1038\/s41598-023-32927-4","volume":"13","author":"A Yndart Arias","year":"2023","unstructured":"Yndart Arias A, Kolishetti N, Vashist A, Madepalli L, Llaguno L, Nair M. Anti-inflammatory effects of CBD in human microglial cell line infected with HIV-1. Sci Rep. 2023;13(1):7376.","journal-title":"Sci Rep"},{"issue":"21","key":"445_CR315","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.1016\/j.neuron.2022.06.023","volume":"110","author":"VW Yong","year":"2022","unstructured":"Yong VW. Microglia in multiple sclerosis: protectors turn destroyers. Neuron. 2022;110(21):3534\u201348.","journal-title":"Neuron"},{"issue":"3","key":"445_CR316","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1389200217666151210142051","volume":"17","author":"O Zendulka","year":"2016","unstructured":"Zendulka O, Dovrtelov\u00e1 G, Noskov\u00e1 K, Turjap M, Sulcov\u00e1 A, Hanus L, et al. Cannabinoids and cytochrome P450 interactions. Curr Drug Metab. 2016;17(3):206\u201326.","journal-title":"Curr Drug Metab"},{"issue":"8","key":"445_CR317","doi-asserted-by":"publisher","first-page":"033310242513647","DOI":"10.1177\/03331024251364753","volume":"45","author":"Q Zhai","year":"2025","unstructured":"Zhai Q, Li H, Chen Q, Zhang N, Huang Y, Pan Y. Microglial TRPV2-mediated neuroinflammation promotes central sensitization through microglial polarization in a vestibular migraine mouse model. Cephalalgia. 2025;45(8):03331024251364753.","journal-title":"Cephalalgia"},{"issue":"12","key":"445_CR318","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41419-021-04450-9","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Hou B, Liang P, Lu X, Wu Y, Zhang X, et al. TRPV1 channel mediates NLRP3 inflammasome-dependent neuroinflammation in microglia. Cell Death Dis. 2021;12(12):1159.","journal-title":"Cell Death Dis"},{"key":"445_CR319","doi-asserted-by":"publisher","first-page":"136648","DOI":"10.1016\/j.neulet.2022.136648","volume":"781","author":"G Zhou","year":"2022","unstructured":"Zhou G, Fu X, Wang L, Cao Y, Zhuang J, Hu J, et al. Palmitoylethanolamide ameliorates neuroinflammation via modulating PPAR-\u03b1 to promote the functional outcome after intracerebral hemorrhage. Neurosci Lett. 2022;781:136648.","journal-title":"Neurosci Lett"},{"key":"445_CR320","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jbiotec.2018.07.031","volume":"284","author":"B Zirpel","year":"2018","unstructured":"Zirpel B, Kayser O, Stehle F. Elucidation of structure-function relationship of THCA and CBDA synthase from Cannabis sativa L. J Biotechnol. 2018;284:17\u201326.","journal-title":"J Biotechnol"},{"issue":"7","key":"445_CR321","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/brain\/awx113","volume":"140","author":"T Zrzavy","year":"2017","unstructured":"Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, Lassmann H. Loss of \u2018homeostatic\u2019microglia and patterns of their activation in active multiple sclerosis. Brain. 2017;140(7):1900\u201313.","journal-title":"Brain"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42238-026-00445-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00445-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-026-00445-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:09:57Z","timestamp":1783483797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42238-026-00445-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":321,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1186\/s42238-026-00445-5","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"13 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"DKF, TMS, and DIM were employees of MedPharm Holdings LLC (dba Bud & Mary\u2019s) during the study period. DIM is a Schedule I U.S. Drug Enforcement Administration (DEA) license holder and MedPharm Holdings is a State of Colorado licensed cannabis research company and a bulk manufacturer of cannabis products for the Colorado adult-use marketplace. MedPharm Holdings has no stake in any products tested in studies reviewed by this manuscript. DIM has received research funding from Kemin Industries. DKF is a former employee of Ebbu LLC, and Canopy Growth Corporation. DKF is author of, but does not hold financial interest in patent applications by Canopy Growth Corporation related to cannabis plants with increased cannabigerolic acid (US20230265444A1, US20240102034A1, CA3150867A1) and increased cannabichromenic acid (US20230413750A1, CA3195455A1). DIM is an Editor for Journal of Cannabis Research. DIM was not involved in the journal\u2019s review of, or decisions related to this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}